<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40394064</article-id><article-id pub-id-type="pmc">PMC12092667</article-id>
<article-id pub-id-type="publisher-id">59948</article-id><article-id pub-id-type="doi">10.1038/s41467-025-59948-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Elucidating the genetic mechanisms governing cytosine base editing outcomes through CRISPRi screens</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gu</surname><given-names>Sifeng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bodai</surname><given-names>Zsolt</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9497-4134</contrib-id><name><surname>Anderson</surname><given-names>Rachel A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0002-2111-0084</contrib-id><name><surname>So</surname><given-names>Hei Yu Annika</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8697-8178</contrib-id><name><surname>Cowan</surname><given-names>Quinn T.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5043-0998</contrib-id><name><surname>Komor</surname><given-names>Alexis C.</given-names></name><address><email>akomor@ucsd.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0168r3w48</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Chemistry and Biochemistry, </institution><institution>University of California, </institution></institution-wrap>San Diego, CA USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0168r3w48</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Moores UCSD Cancer Center, </institution><institution>University of California, </institution></institution-wrap>San Diego, CA USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0168r3w48</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Sanford Stem Cell Institute, </institution><institution>University of California, </institution></institution-wrap>San Diego, CA USA </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>4685</elocation-id><history><date date-type="received"><day>26</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>9</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Cytosine base editors enable programmable and efficient genome editing using an intermediate featuring a U&#x02022;G mismatch across from a DNA nick. This intermediate facilitates two major outcomes, C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C point mutations, and it is not currently well-understood which DNA repair factors are involved. Here, we couple reporters for cytosine base editing activity with knockdown of 2015 DNA processing genes to identify genes involved in these two outcomes. Our data suggest that mismatch repair factors facilitate C&#x02022;G to T&#x02022;A outcomes, while C&#x02022;G to G&#x02022;C outcomes are mediated by RFWD3, an E3 ubiquitin ligase. We also propose that XPF, a 3&#x02019;-flap endonuclease, and LIG3, a DNA ligase, are involved in repairing the intermediate back to the original C&#x02022;G base pair. Our results demonstrate that competition and collaboration among different DNA repair pathways shape cytosine base editing outcomes.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">Cytosine base editors use an uracil-containing intermediate to introduce C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C point mutations. Here, the authors couple gene knockdown with reporters of these two cytosine base editing outcomes to identify the cellular DNA repair factors that process this intermediate.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Genetic engineering</kwd><kwd>CRISPR-Cas9 genome editing</kwd><kwd>DNA damage and repair</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000001</institution-id><institution>National Science Foundation (NSF)</institution></institution-wrap></funding-source><award-id>MCB-2048207</award-id><principal-award-recipient><name><surname>Komor</surname><given-names>Alexis C.</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100001309</institution-id><institution>Research Corporation for Science Advancement (Research Corporation)</institution></institution-wrap></funding-source><award-id>27975</award-id><principal-award-recipient><name><surname>Bodai</surname><given-names>Zsolt</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000057</institution-id><institution>U.S. Department of Health &#x00026; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution></institution-wrap></funding-source><award-id>T32GM146648</award-id><award-id>T32GM008326</award-id><principal-award-recipient><name><surname>Anderson</surname><given-names>Rachel A.</given-names></name><name><surname>Cowan</surname><given-names>Quinn T.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Base editing technologies facilitate the efficient and precise introduction of point mutations into the genome without the use of DNA double-strand breaks (DSBs). Currently, there are two major classes of base editors, cytosine base editors (CBEs) and adenine base editors (ABEs)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. CBEs are generally protein fusion constructs consisting of a catalytically impaired Cas nuclease linked to a cytidine deaminase enzyme specific for single-stranded DNA (ssDNA) substrates. Upon localization of the Cas protein to its target DNA sequence, hybridization of a short piece of RNA called the single guide RNA (sgRNA) to its complimentary DNA strand exposes a small stretch of ssDNA on the non-complementary strand to the deaminase enzyme (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). This exposure allows the cytidine deaminase to gain access to and deaminate cytosine bases to uracil within this ssDNA window<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Furthermore, most CBEs use a Cas nickase (Cas9n), which introduces a single-strand break on the sgRNA-complementary stand. Consequently, CBEs generate a unique type of DNA damage, featuring a U&#x02022;G mismatch with a DNA nick 5&#x02019; upstream from the mismatch on the G-containing strand (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Development and implementation of CRISPRi screens for identifying genes involved in processing cytosine base editing intermediates.</title><p><bold>a</bold> Schematic of cytosine base editing. Binding of Cas9n to a genomic locus of interest, facilitated by base-pairing between the DNA and the sgRNA, exposes a window of single-stranded DNA to the cytidine deaminase. Cytosines within this window are deaminated to uracil, while the Cas9n cleaves the opposite strand, to produce a U&#x02022;G intermediate with a nick. This intermediate is processed by the cell to produce either a C&#x02022;G to T&#x02022;A outcome (top), or C&#x02022;G to non-T&#x02022;A outcomes, the most common of which is a C&#x02022;G to G&#x02022;C (bottom). The genetic determinants for the distribution between the C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C outcomes are still unclear. <bold>b</bold> Schematic of the generation of CRISPRi-expressing K562 cell lines with integrated dox-inducible rA1-SaBE4(&#x00394;UGI). The CRISPRi constructs shown in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a</xref> were transduced into K562 cells, and successfully transduced cells were selected using fluorescence-activated cell sorting (FACS). The resulting CRISPRi-expressing K562 cells were then transfected with the dox-inducible rA1-SaBE4(&#x00394;UGI) construct shown in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a</xref> and a PiggyBac transposase. Cells with rA1-SaBE4(&#x00394;UGI) successfully integrated were selected for with a hygromycin treatment. <bold>c</bold> Timeline of the C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C screens. For both screens, the cell line described in (<bold>b</bold>) was transduced with the lentiviral reporter vectors described in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2b</xref> at a low multiplicity of infection (MOI&#x02009;&#x0003c;&#x02009;0.1). Volcano plots from the C&#x02022;G to T&#x02022;A (<bold>d</bold>) and C&#x02022;G to G&#x02022;C (<bold>e</bold>) screens are shown. Representative genes from enriched pathways identified via GOBP analysis are highlighted in colors indicated in the figure legends. Each screen was conducted in <italic>n</italic>&#x02009;=&#x02009;2 independent replicates. Gene phenotypes (median log<sub>2</sub> fold change of 5 CRISPRi sgRNAs) and <italic>P</italic> values were calculated using the MAGeCK RRA. MAGeCK uses two-sided negative binomial tests with FDR correction at the sgRNA level and one-sided permutation-adjusted RRA tests at the gene level. Source data are provided as a <xref rid="MOESM6" ref-type="media">Source Data</xref> file. Created in BioRender. Gu, S. (2025) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/b8hi5u8">https://BioRender.com/b8hi5u8</ext-link>.</p></caption><graphic xlink:href="41467_2025_59948_Fig1_HTML" id="d33e290"/></fig></p><p id="Par4">Cellular processing of this DNA damage intermediate leads to two major mutational outcomes, C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C conversions (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). C&#x02022;G to A&#x02022;T conversions and indel products can also be introduced, although at much lower rates. It has been previously shown that the endogenous DNA repair enzyme uracil-DNA glycosylase (UNG) plays an important role in the relative distribution of these outcomes by excising the uracil intermediate into an abasic site, which leads to C&#x02022;G to non-T&#x02022;A outcomes<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Therefore, canonical C&#x02022;G to T&#x02022;A base editors (which we will refer to as CBEs here) are covalently fused to one or more copies of an uracil-DNA glycosylase inhibitor (UGI). These inhibitors suppress uracil excision by UNG, thereby favoring the C&#x02022;G to T&#x02022;A outcome. On the other hand, the more recently developed C&#x02022;G to G&#x02022;C base editors (CGBEs) utilize a variety of different DNA repair effectors, including but not limited to UNG, X-Ray Repair Cross Complementing 1 (XRCC1), and RNA-binding motif protein X-linked (RBMX)<sup><xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref></sup>. These effectors serve to bias the cellular repair processes towards the C&#x02022;G to G&#x02022;C outcome. Studies have revealed that the sequence context surrounding the uracil intermediate greatly influences these two outcomes as well<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par5">Prior work to investigate cytosine base editing mechanisms have utilized Repair-seq screens, in which the editing site is directly sequenced in the same amplicon as the sgRNA used for gene knockdown<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. These screens were performed in HeLa or HEK293T cells, utilized transient transfection of the base editor, and the target site was a non-transcribed locus with multiple target Cs. These studies found that UNG and the E3 ubiquitin ligase RFWD3 had the largest impact on the C&#x02022;G to G&#x02022;C outcome upon knockdown and found UNG and DSB repair factors to be involved in the indel outcome. Overall, beyond the involvement of UNG in producing C&#x02022;G to non-T&#x02022;A outcomes, a detailed explanation of the genetic mechanisms governing cytosine base editing outcomes is still lacking<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. In particular, we were interested to identify the cellular repair factors involved in producing the desired C&#x02022;G to T&#x02022;A outcome.</p><p id="Par6">We reasoned that coupling gene knockdown with fluorescent reporters for the two major cytosine base editing outcomes could further illuminate the underlying genetic mechanisms governing these outcomes. We therefore developed and executed two CRISPR-interference (CRISPRi) screens in K562 cells that measured the impact of knockdown of 2015 individual genes on cytosine base editing activity at genomically integrated, actively transcribed, C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C fluorescent reporters in which only a single target C was edited. We additionally comprehensively analyzed and validated the hits from our screens across multiple target sites and cell lines. We find that MutS&#x003b1; (the MSH2/MSH6 heterodimer), the mismatch repair (MMR) recognition complex, is involved in facilitating C&#x02022;G to T&#x02022;A outcomes. While previous work on APOBEC-mediated carcinogenesis has identified MMR as a source of mutagenesis<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, its role in cytosine base editing has not been demonstrated previously. We also find that RFWD3, an E3 ubiquitin ligase, mediates a translesion synthesis pathway that specifically leads to the C&#x02022;G to G&#x02022;C outcome (and not the C&#x02022;G to A&#x02022;T outcome)<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. Finally, we show that XPF (encoded by <italic>ERCC4</italic>), a 3&#x02019;-flap endonuclease, is involved in repairing the intermediate back to the original C&#x02022;G base pair. This study fills in several key knowledge gaps in our understanding of cytosine base editing.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Development of fluorescent reporters for CBE outcomes</title><p id="Par7">To systematically identify enzymes that affect cytosine base editing outcomes, we coupled fluorescent reporters for C&#x02022;G to T&#x02022;A or C&#x02022;G to G&#x02022;C editing with CRISPRi screens<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Our C&#x02022;G to T&#x02022;A fluorescent reporter leveraged a blue fluorescent protein (BFP) variant that is converted into green fluorescent protein (GFP) upon a single C&#x02022;G to T&#x02022;A conversion (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a</xref>)<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup> Our C&#x02022;G to G&#x02022;C fluorescent reporter utilized a non-fluorescent GFP variant that is converted into functional GFP upon a single C&#x02022;G to G&#x02022;C conversion (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1b</xref>). We also incorporated a frameshifted mCherry into this reporter construct to report on indel formation<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Notably, we codon optimized both constructs within the protospacer sequences to remove any bystander cytosines, ensuring only one target C lies within the editing window.</p><p id="Par8">To test our reporter systems, HEK293T cells were transfected with plasmids encoding one of the reporters, a SaBE4(&#x00394;UGI) construct (a cytidine deaminase fused to the PAM-relaxed KKH <italic>Staphylococcus aureus</italic> Cas9n<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> via an optimized 32 amino acid linker<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>), and a sgRNA targeting the CBE to the mutation of interest (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a, b</xref>). In this initial round of experiments, we evaluated three different SaBE4(&#x00394;UGI) constructs, in which the deaminase domain was rA1 (APOBEC1 from <italic>Rattus norvegicus</italic>), eA3A (an engineered human APOBEC3A) or RrA3F (APOBEC3F from <italic>Rhinopithecus roxellana</italic>)<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. Further, we used SaCas9-derived CBEs to avoid sgRNA exchange between the CBE and SpCas9-derived CRISPRi machinery in future experiments. After 72&#x02009;h, cells were harvested and analyzed by flow cytometry for either BFP to GFP conversion (for the C&#x02022;G to T&#x02022;A reporter) or GFP turn-on (for the C&#x02022;G to G&#x02022;C reporter)<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. We found that rA1 outperformed both the RrA3F and eA3A on both reporters. The rA1-derived CBE facilitated GFP fluorescence turn-on in 45.2% and 13.6% of cells for the C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C reporters, respectively, compared to 40.4% and 7.7% for the RrA3F-derived CBE, and 25.2% and 8.4% for the eA3A-derived CBE (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1c, d</xref>). We observed no mCherry fluorescence turn-on with the C&#x02022;G to G&#x02022;C reporter, which we attribute to plasmid degradation rather than repair following in situ DSB introduction. We therefore used the rA1-derived SaBE4(&#x00394;UGI) construct, hereafter referred to as rA1-SaBE4(&#x00394;UGI), for subsequent experiments.</p></sec><sec id="Sec4"><title>Coupling fluorescent reporters for CBE outcomes with CRISPRi screens</title><p id="Par9">To develop the two screening systems, we first generated two stable CRISPRi-expressing K562 cell lines (one for each screen, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a</xref>) via lentiviral transduction<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. We then incorporated doxycycline-inducible rA1-SaBE4(&#x00394;UGI) into both cell lines via PiggyBac transposition (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a</xref>). Finally, we generated lentiviral reporter vectors containing the C&#x02022;G to T&#x02022;A or C&#x02022;G to G&#x02022;C reporter, a Sp-sgRNA cassette encoding the CRISPRi Sp-sgRNA library, and a Sa-sgRNA cassette guiding the CBE to the reporter (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2b</xref>). The CRISPRi Sp-sgRNA library is detailed in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2c</xref> and Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">1</xref>.</p><p id="Par10">We conducted the screens, each in duplicate, according to Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref> (see Methods). In the doxycycline-treated cells, we observed on average 13.2&#x02009;&#x000b1;&#x02009;0.4% of cells with GFP fluorescence (C&#x02022;G to T&#x02022;A outcome) in the C&#x02022;G to T&#x02022;A screens, and 12.9&#x02009;&#x000b1;&#x02009;1.7% of cells with GFP fluorescence (C&#x02022;G to G&#x02022;C outcome) and 2.0&#x02009;&#x000b1;&#x02009;0.1% of cells with mCherry fluorescence (C&#x02022;G to +2 frameshift indel outcome) in the C&#x02022;G to G&#x02022;C screens (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3a, b</xref>). We then used fluorescence-activated cell sorting (FACS) to sort a subset of the doxycycline-treated cells into the various populations of interest. Unfortunately, the number of cells collected from the mCherry+ population in the C&#x02022;G to G&#x02022;C screens was too low to obtain enough sgRNA coverage to acquire reliable data on sgRNA enrichment or depletion in this population. Unsorted, doxycycline-treated cells, and untreated cells served as bulk population controls.</p><p id="Par11">We validated the screens by first sequencing the <italic>BFP</italic> (C&#x02022;G to T&#x02022;A screen) or <italic>dGFP</italic> (C&#x02022;G to G&#x02022;C screen) loci of the unsorted and sorted populations and observed both stringent doxycycline induction and significant enrichment of the editing outcomes of interest in the appropriate sorted populations (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3c, d</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Discussion</xref>). We then amplified and sequenced the CRISPRi Sp-sgRNA regions of each population of cells with larger than 200X sequencing depth using next generation sequencing (NGS) (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4a, d</xref>). As an initial validation of the screen, we monitored dropout of essential genes and found effective gene knockdown in both screens (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4e, h</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Discussion</xref>). We additionally analyzed the data to identify genes that are synthetic lethal to CBE expression and/or activity (i.e., genes whose knockdown causes preferential cell death in cells in which CBE is expressed) and notably did not observe any pathways that were significantly enriched upon CBE expression (See&#x000a0;<xref rid="MOESM1" ref-type="media">Supplementary Discussion</xref>).</p></sec><sec id="Sec5"><title>Identification of genes governing the C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing outcomes</title><p id="Par12">To identify genes influencing C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C outcomes, we compared the distributions of the CRISPRi Sp-sgRNAs in the GFP+ populations to that of their respective pre-sorted bulk populations (bulk, +dox samples) for both screens. Depending on the screen, genes whose sgRNAs are depleted in the GFP+ population are expected to be those that promote the C&#x02022;G to T&#x02022;A or C&#x02022;G to G&#x02022;C outcome, whereas genes whose sgRNAs are enriched in this population are expected to be those that inhibit these outcomes. We observed good correlation (Pearson&#x02019;s r&#x02009;&#x0003e;&#x02009;0.7) between the log<sub>2</sub> fold changes of the CRISPRi Sp-sgRNAs in the GFP+ population compared to the initial day 0 population for the two replicates from both screens (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5a&#x02013;c</xref>). However, we observed a low correlation (Pearson&#x02019;s r&#x02009;&#x0003c;&#x02009;0.7) between the log<sub>2</sub> fold changes of the CRISPRi Sp-sgRNAs in the GFP+ population compared to the unsorted population on day 13 (bulk +dox samples) for the two replicates (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5b&#x02013;d</xref>). We believe this is not indicative of low screen quality and is due to only a small number of genes from our library being able to single-handedly impact base editing outcomes.</p><p id="Par13">We used the MAGeCK RRA (Model-based Analysis of Genome-wide CRISPR-Cas9 Knockout Robust Rank Aggregation) algorithm to identify genes whose sgRNAs were consistently depleted or enriched in the GFP+ populations (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d, e</xref>). <italic>UNG</italic>, which served as our positive control, was the strongest hit in both screens. UNG is known to excise the uracil intermediate during base excision repair (BER) and initiate either conversion back to the initial C&#x02022;G base pair, or conversion to the C&#x02022;G to G&#x02022;C outcome. Consistent with this mechanism, <italic>UNG</italic> was enriched in the GFP+ population in the C&#x02022;G to T&#x02022;A screen and depleted in the GFP+ population in the C&#x02022;G to G&#x02022;C screen. A gene ontology biological process (GOBP) analysis of the C&#x02022;G to T&#x02022;A screen results revealed that sgRNAs targeting genes involved in DNA repair, cell cycle checkpoints, and regulation of mRNA stability were enriched, and sgRNAs targeting genes encoding for the MutS&#x003b1; complex (<italic>MSH2</italic> and <italic>MSH6</italic>) and two chromatin remodeling enzymes (<italic>TRIM28</italic> and <italic>KAT7</italic>) were significantly depleted (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>, full list in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">2</xref>). A GOBP analysis of the C&#x02022;G to G&#x02022;C screen results also identified sgRNAs targeting DNA repair genes, especially those involved in nucleotide excision repair (NER), were enriched, and sgRNAs targeting other DNA repair genes (<italic>UNG</italic> and <italic>RFWD3</italic>), as well as DNA replication genes were depleted (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e</xref>, full list in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">3</xref>).</p><p id="Par14">Taking into account <italic>p</italic>-values, fold-change values, and the GOPB analysis, we selected 14 top-ranked hits from the C&#x02022;G to T&#x02022;A screen and 9 top-ranked hits from the C&#x02022;G to G&#x02022;C screen for further validation (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6a, b</xref>). We additionally included 7 genes that have been hypothesized to resolve the CBE intermediate but did not show up as hits from the screens<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Specifically, we included three BER genes, two error-prone Y-family polymerases, one gene involved in DNA damage check point and one NER gene. Lastly, we included 3 non-targeting sgRNA controls.</p></sec><sec id="Sec6"><title>Initial validations suggest C&#x02022;G to T&#x02022;A editing relies on MSH2 and MSH6 and is hindered by LIG3 and UNG</title><p id="Par15">For each gene chosen for validation, we chose the two best-performing CRISPRi Sp-sgRNAs, as determined by the two largest log<sub>2</sub> fold changes in the screening results. We individually incorporated each CRISPRi Sp-sgRNA into either the C&#x02022;G to T&#x02022;A or C&#x02022;G to G&#x02022;C lentiviral reporter vector, depending on from which screen the gene was a hit. To generate stable knockdown cell lines for each gene of interest, we then individually transduced these vectors into the CRISPRi K562 cell line with dox-inducible rA1-SaBE4(&#x00394;UGI) at a MOI&#x02009;&#x0003c;&#x02009;0.3. We enriched for transduced cells with a puromycin selection, and then added doxycycline to induce rA1-SaBE4(&#x00394;UGI) expression for 7 days. Editing efficiencies at the <italic>BFP/dGFP</italic> loci were quantified with NGS (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref> and Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>, <xref rid="MOESM1" ref-type="media">8</xref>). We then computed a z-score for each CRISPRi Sp-sgRNA relative to the non-targeting sgRNA controls, with sgRNAs that demonstrated absolute z-scores &#x0003e; 3 considered to have strong impacts on editing outcomes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>CRISPRi screen results and validation.</title><p><bold>a</bold> Schematic of hit validation strategy. The CRISPRi Sp-sgRNAs from Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6a, b</xref> were individually cloned into one of the constructs from Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2b</xref> (depending on which screen the potential gene hit was identified from). These were then individually transduced into the cell lines from Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref> to produce stable knockdown cell lines for genes of interest. Doxycycline was added to induce rA1-SaBE4(&#x00394;UGI) expression, and base editing was allowed to occur for 7 days. The <italic>BFP</italic> or <italic>dGFP</italic> locus (site of editing) was then sequenced with NGS to quantify editing efficiencies. Created in BioRender. Gu, S. (2025) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/7923b17">https://BioRender.com/7923b17</ext-link>. <bold>b</bold> Z-scores of changes in C&#x02022;G to T&#x02022;A editing efficiencies for each CRISPRi Sp-sgRNA (x-axis) were plotted against the z-scores of changes in C&#x02022;G to G&#x02022;C editing efficiencies (y-axis). For both screens, sgRNAs that have |z-scores&#x02009;|&#x02009;&#x0003e;&#x02009;3 in either the C&#x02022;G to T&#x02022;A or C&#x02022;G to G&#x02022;C editing outcome are considered to have strong effects and are highlighted in color corresponding to their respective screen from which they were identified as a hit. Absolute C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing efficiencies at the single-copy, genomically-integrated C&#x02022;G to T&#x02022;A (<bold>c</bold>) and C&#x02022;G to G&#x02022;C (<bold>d</bold>) reporters upon knockdown of selected genes with the best-performing CRISPRi sgRNAs are shown. Negative control (NC) samples are also shown, in which cells were treated identically using non-targeting sgRNAs. For the NC samples, the values represent the mean obtained from 3 different non-targeting sgRNAs, with <italic>n</italic>&#x02009;=&#x02009;3 biological replicates each. For all other samples, the values represent the mean of <italic>n</italic>&#x02009;=&#x02009;2 biological replicates. The shaded regions represent the ranges that are within three STDs from the mean C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing efficiencies of the NC samples. Heatmaps represent log<sub>2</sub> (fold change) (LFC) in C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing efficiencies relative to the corresponding means of non-targeting sgRNAs. Source data are provided as a <xref rid="MOESM6" ref-type="media">Source Data</xref> file.</p></caption><graphic xlink:href="41467_2025_59948_Fig2_HTML" id="d33e623"/></fig></p><p id="Par16">Out of the hits from the C&#x02022;G to T&#x02022;A screen, we found that knockdown of <italic>MSH2</italic> and <italic>MSH6</italic> led to the most substantial decreases in C&#x02022;G to T&#x02022;A editing efficiencies, whereas knockdown of <italic>LIG3</italic> and <italic>UNG</italic> caused the most significant increases in C&#x02022;G to T&#x02022;A editing efficiencies (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b, c</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>). The C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing efficiencies of the C&#x02022;G to T&#x02022;A reporter vector in the non-targeting CRISPRi Sp-sgRNA samples averaged 15.6&#x02009;&#x000b1;&#x02009;1.7% and 6.6&#x02009;&#x000b1;&#x02009;0.7%, respectively. Knockdown of <italic>MSH2</italic> and <italic>MSH6</italic> decreased C&#x02022;G to T&#x02022;A editing efficiencies by 2.1&#x02009;&#x000b1;&#x02009;0.3-fold (to 7.5&#x02009;&#x000b1;&#x02009;0.7%) and 1.8&#x02009;&#x000b1;&#x02009;0.2-fold (to 8.5&#x02009;&#x000b1;&#x02009;0.1%), respectively, while maintaining C&#x02022;G to G&#x02022;C editing efficiencies at 5.1&#x02009;&#x000b1;&#x02009;0.6% and 6.0&#x02009;&#x000b1;&#x02009;0.1%, respectively. Meanwhile, knockdown of <italic>LIG3</italic> increased C&#x02022;G to T&#x02022;A editing efficiency by 1.5&#x02009;&#x000b1;&#x02009;0.2-fold (to 23.8&#x02009;&#x000b1;&#x02009;1.7%) while maintaining C&#x02022;G to G&#x02022;C editing efficiency at 7.0&#x02009;&#x000b1;&#x02009;0.1%. <italic>UNG</italic> knockdown robustly increased C&#x02022;G to T&#x02022;A editing efficiency by 2.1&#x02009;&#x000b1;&#x02009;0.3-fold and decreased C&#x02022;G to G&#x02022;C editing efficiency by 2.0&#x02009;&#x000b1;&#x02009;0.3-fold, as expected. These findings are consistent with a mechanism in which the C&#x02022;G to T&#x02022;A outcome is facilitated by MSH2 and MSH6, and inhibited by LIG3 and UNG.</p><p id="Par17">In addition, we found that knockdown of <italic>TRIM28</italic>, a transcriptional repressor, and <italic>KAT7</italic>, a histone acetyltransferase, both decreased C&#x02022;G to T&#x02022;A editing efficiencies by around 1.5-fold while knockdown of <italic>DHX36</italic>, a DNA/RNA guanine-quadruplex helicase, increased the C&#x02022;G to T&#x02022;A editing efficiency by 1.3&#x02009;&#x000b1;&#x02009;0.1-fold. These genes participate in multiple DNA repair pathways as well as additional biological processes such as chromatin remodeling and regulation of mRNA stability<sup><xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref></sup>. Their exact roles in processing base editing intermediates are likely multifaceted and may involve influencing base editor expression levels and/or impacting accessibility of the target site.</p></sec><sec id="Sec7"><title>Initial validations suggest C&#x02022;G to G&#x02022;C editing depends on RFWD3 and UNG and is inhibited by XPF and XPA</title><p id="Par18">Out of the hits from the C&#x02022;G to G&#x02022;C screen, we found that knockdown of <italic>ERCC4</italic> and <italic>XPA</italic> increased C&#x02022;G to G&#x02022;C editing efficiencies most significantly, while knockdown of <italic>RFWD3</italic> and <italic>UNG</italic> decreased C&#x02022;G to G&#x02022;C editing efficiencies most significantly (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>, <xref rid="Fig2" ref-type="fig">d</xref>, and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>). The C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing efficiencies of the C&#x02022;G to G&#x02022;C reporter vector in the non-targeting CRISPRi Sp-sgRNA samples averaged 41.7&#x02009;&#x000b1;&#x02009;3.0% and 17.3&#x02009;&#x000b1;&#x02009;0.5%, respectively. Knockdown of <italic>ERCC4</italic> and <italic>XPA</italic> increased C&#x02022;G to G&#x02022;C editing efficiencies by 1.6&#x02009;&#x000b1;&#x02009;0.1-fold (to 26.9&#x02009;&#x000b1;&#x02009;0.1%) and 1.3&#x02009;&#x000b1;&#x02009;0.1-fold (to 22.7&#x02009;&#x000b1;&#x02009;0.4%), respectively. XPF and XPA (the proteins encoded by <italic>ERCC4</italic> and <italic>XPA</italic>, respectively), together with ERCC1 are known to form a ternary protein complex that acts as a structure-specific endonuclease, specifically cleaving the DNA backbone at junctions between double-stranded and single-stranded DNA<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. However, we did not observe knockdown of <italic>ERCC1</italic> to significantly affect either the C&#x02022;G to G&#x02022;C or C&#x02022;G to T&#x02022;A outcome (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>). Knockdown of <italic>RFWD3</italic> decreased C&#x02022;G to G&#x02022;C editing efficiency by 1.8&#x02009;&#x000b1;&#x02009;0.1-fold (to 9.7&#x02009;&#x000b1;&#x02009;0.2%), while maintaining C&#x02022;G to T&#x02022;A editing efficiency at 44.7&#x02009;&#x000b1;&#x02009;1.1%. Knockdown of <italic>UNG</italic> decreased C&#x02022;G to G&#x02022;C editing efficiency by 2.7&#x02009;&#x000b1;&#x02009;0.2-fold (to 6.4&#x02009;&#x000b1;&#x02009;0.5%) and increased C&#x02022;G to T&#x02022;A editing efficiency by 1.6&#x02009;&#x000b1;&#x02009;0.1-fold (to 67.4&#x02009;&#x000b1;&#x02009;1.3%). These results are consistent with the C&#x02022;G to G&#x02022;C outcome being dependent on <italic>RFWD3</italic> and <italic>UNG</italic> and inhibited by <italic>ERCC4</italic> and <italic>XPA</italic>.</p><p id="Par19">Unexpectedly, while both <italic>MSH2</italic> and <italic>POLD1</italic> CRISPRi Sp-sgRNAs were enriched in the GFP+ population in the C&#x02022;G to G&#x02022;C screen, their knockdown primarily impacted C&#x02022;G to T&#x02022;A editing, leading to a 1.4-fold decrease in C&#x02022;G to T&#x02022;A editing efficiency. By decreasing the absolute C&#x02022;G to T&#x02022;A editing efficiencies while maintaining the C&#x02022;G to G&#x02022;C editing efficiencies, these two gene knockdowns led to increases in the relative C&#x02022;G to G&#x02022;C outcome (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">9a, b</xref>). Specifically, the average relative percent of edited reads with a C&#x02022;G to G&#x02022;C outcome was 23.7&#x02009;&#x000b1;&#x02009;0.2% in the negative control sgRNA samples, which increased to 30.9&#x02009;&#x000b1;&#x02009;0.1% upon <italic>MSH2</italic> knockdown, and 27.6&#x02009;&#x000b1;&#x02009;0.9% upon <italic>POLD1</italic> knockdown. The effect of <italic>MSH2</italic> knockdown on editing outcomes was consistent with both reporters. Importantly, these data reveal that the C&#x02022;G to T&#x02022;A outcome is also dependent on <italic>POLD1</italic>, which encodes for the catalytic subunit of the replicative polymerase <inline-formula id="IEq1"><alternatives><tex-math id="d33e767">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\delta }}}}$$\end{document}</tex-math><mml:math id="d33e772"><mml:mi mathvariant="normal">&#x003b4;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq1.gif"/></alternatives></inline-formula> that is involved in MMR<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p><p id="Par20">Because we quantified editing with NGS, we were able to also evaluate the impact of each selected gene knockdown on the C&#x02022;G to A&#x02022;T outcome, which is the least frequent cytosine base editing outcome (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10</xref>). UNG knockdown reduced both the C&#x02022;G to G&#x02022;C and C&#x02022;G to A&#x02022;T editing efficiencies by 2.7&#x02009;&#x000b1;&#x02009;0.2-fold and 3.4&#x02009;&#x000b1;&#x02009;0.3-fold, respectively (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10b</xref>), implying that both outcomes rely on abasic site formation via UNG-mediated uracil excision. Surprisingly, while knockdown of <italic>RFWD3</italic> caused a 1.8&#x02009;&#x000b1;&#x02009;0.1-fold decrease in C&#x02022;G to G&#x02022;C editing efficiency, its knockdown caused a modest 1.2&#x02009;&#x000b1;&#x02009;0.1-fold increase in C&#x02022;G to A&#x02022;T editing efficiency (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10b</xref>)<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. The contrasting effects of <italic>RFWD3</italic> knockdown on these two outcomes suggest the existence of distinct translesion synthesis sub-pathways, with RFWD3 promoting the one that specifically leads to the C&#x02022;G to G&#x02022;C outcome. Knockdown of <italic>ERCC4</italic> and <italic>XPA</italic> elevated both the C&#x02022;G to G&#x02022;C and C&#x02022;G to A&#x02022;T editing efficiencies simultaneously (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10b</xref>), consistent with an inhibitory role of XPF and XPA in these outcomes.</p></sec><sec id="Sec8"><title>Selected genes were further validated at two endogenous sites in K562 cells</title><p id="Par21">To further validate these hits beyond the transduced lentiviral reporters (the <italic>BFP</italic> and <italic>dGFP</italic> genes), we chose seven genes, <italic>UNG</italic>, <italic>MSH2</italic>, <italic>MSH6</italic>, <italic>POLD1</italic>, <italic>LIG3</italic>, <italic>RFWD3</italic> and <italic>ERCC4</italic>, to validate at two endogenous sites, <italic>HEK3</italic> and <italic>RNF2</italic>. We replaced the <italic>BFP</italic>-targeting Sa-sgRNA spacer in the C&#x02022;G to T&#x02022;A lentiviral reporter vector with either the <italic>HEK3</italic>- or <italic>RNF2</italic>-targeting spacer sequences. We then individually incorporated the best CRISPRi Sp-sgRNA for each gene and three non-targeting sgRNAs into the vector and separately transduced each sgRNA-expressing vector into the CRISPRi K562 cell line with dox-inducible rA1-SaBE4(&#x00394;UGI) at a MOI&#x02009;&#x0003c;&#x02009;0.3. Editing at these two endogenous sites was allowed for 7 days before the <italic>HEK3</italic> or <italic>RNF2</italic> loci were amplified and quantified by NGS. Additionally, knockdown levels of the target genes in these cell lines were quantified by RT-qPCR (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11a</xref>).</p><p id="Par22">Overall, we observed consistent trends with our previous observations at the <italic>GFP</italic> reporters. Knockdown of MMR genes (<italic>MSH2</italic>, <italic>MSH6</italic>) and <italic>POLD1</italic> reduced C&#x02022;G to T&#x02022;A editing efficiencies at both sites. <italic>POLD1</italic> knockdown led to the most significant (1.4&#x02009;&#x000b1;&#x02009;0.2-fold) decrease in absolute C&#x02022;G to T&#x02022;A editing at the <italic>HEK3</italic> site, while <italic>MSH2</italic> knockdown resulted in the most substantial (1.6&#x02009;&#x000b1;&#x02009;0.1-fold) reduction in absolute C&#x02022;G to T&#x02022;A editing efficiency at the <italic>RNF2</italic> site (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>). In contrast, knockdown of <italic>LIG3</italic> increased the absolute C&#x02022;G to T&#x02022;A editing efficiencies by around 1.4-fold at both the <italic>HEK3</italic> and <italic>RNF2</italic> sites. Relative C&#x02022;G to T&#x02022;A outcomes (normalized to total editing) at both sites were impacted similarly upon knockdown of these four genes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11b, c</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Validation of selected genes at two endogenous sites in K562.</title><p><bold>a</bold>, <bold>b</bold> The dCas9-BFP-KRAB and dox-inducible rA1-SaBE4(&#x00394;UGI) expressing K562 cell line (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>) was transduced with the C&#x02022;G to T&#x02022;A lentiviral reporter vector (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2b</xref>), in which the <italic>BFP</italic>-targeting Sa-sgRNA spacer was replaced with either a <italic>HEK3</italic>- or <italic>RNF2</italic>-targeting spacer, and the CRISPRi Sp-sgRNA was targeted to the specific gene indicated. After a 3-day puromycin selection, doxycycline was added and rA1-SaBE4(&#x00394;UGI) expression was induced for 7 days. The <italic>HEK3</italic> or <italic>RNF2</italic> locus (site of editing) was then sequenced with NGS to quantify editing efficiencies. Editing efficiencies of all outcomes at the two endogenous sites, <italic>HEK3</italic> (<bold>a</bold>) and <italic>RNF2</italic> (<bold>b</bold>), upon knockdown of selected genes are shown. Negative control (NC) samples are also shown, in which cells were treated identically using non-targeting sgRNAs. For the NC samples, the bars represent the mean obtained from 3 non-targeting sgRNAs, with <italic>n</italic>&#x02009;=&#x02009;4 biological replicates each. For all other samples, the bars represent the mean of <italic>n</italic>&#x02009;=&#x02009;2 (<italic>MSH6</italic> and <italic>POLD1</italic>), 3 (<italic>LIG3</italic>), or 4 (<italic>UNG</italic>, <italic>MSH2</italic>, <italic>RFWD3</italic>, and <italic>ERCC4</italic>) biological replicates. The shaded regions represent the ranges that are within three STDs from the mean C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C editing efficiencies of the NC samples. <bold>c</bold>, <bold>d</bold> Cells were treated as described in (<bold>a</bold>, <bold>b</bold>), but with the <italic>BFP</italic> gene of the reporter construct replaced with cDNA encoding for the corresponding knocked-down gene. Shown are the fold-changes in editing efficiencies of all outcomes upon knockdown of selected genes at the two endogenous sites, <italic>HEK3</italic> (<bold>c</bold>) and <italic>RNF2</italic> (<bold>d</bold>), in comparison to the average editing efficiencies of 3 negative control samples without knockdown. The gene knockdown effects on all editing outcomes (solid color bars) at both sites were fully or partially rescued by the re-expression of the corresponding protein (striped bars). The bars represent the mean fold-changes for <italic>n</italic>&#x02009;=&#x02009;4 and <italic>n</italic>&#x02009;=&#x02009;3 biological replicates for the KD condition at <italic>HEK3</italic> and <italic>RNF2</italic> site, respectively, and <italic>n</italic>&#x02009;=&#x02009;2 biological replicates for cDNA re-expression condition. KD, knockdown. Source data are provided as a <xref rid="MOESM6" ref-type="media">Source Data</xref> file.</p></caption><graphic xlink:href="41467_2025_59948_Fig3_HTML" id="d33e1039"/></fig></p><p id="Par23">Knockdown of <italic>RFWD3</italic> did not lead to a substantial decrease in absolute C&#x02022;G to G&#x02022;C editing efficiency at the <italic>HEK3</italic> site, but its knockdown did increase both C&#x02022;G to T&#x02022;A and C&#x02022;G to A&#x02022;T editing efficiencies by 1.3&#x02009;&#x000b1;&#x02009;0.2-fold and 1.5&#x02009;&#x000b1;&#x02009;0.2-fold, respectively. At the <italic>RNF2</italic> site, <italic>RFWD3</italic> knockdown significantly decreased the absolute C&#x02022;G to G&#x02022;C editing efficiency by 1.9&#x02009;&#x000b1;&#x02009;0.1-fold, while also promoting both C&#x02022;G to T&#x02022;A and C&#x02022;G to A&#x02022;T editing efficiencies by around 1.2-fold (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>). As a result, <italic>RFWD3</italic> knockdown selectively suppressed the relative C&#x02022;G to G&#x02022;C outcome while promoting all relative C&#x02022;G to non-G&#x02022;C outcomes at both sites (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11b, c</xref>). Knockdown of <italic>ERCC4</italic> increased all outcomes at both the <italic>HEK3</italic> and <italic>RNF2</italic> sites (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>). This effect was most notable at the <italic>HEK3</italic> site, in which C&#x02022;G to T&#x02022;A, C&#x02022;G to G&#x02022;C, C&#x02022;G to A&#x02022;T, and C&#x02022;G to indels all increased by 1.6&#x02009;&#x000b1;&#x02009;0.3-fold, 2.0&#x02009;&#x000b1;&#x02009;0.2-fold, 2.1&#x02009;&#x000b1;&#x02009;0.2-fold, and 2.5&#x02009;&#x000b1;&#x02009;0.3-fold, respectively. As a result, the total editing efficiency increased by 1.9&#x02009;&#x000b1;&#x02009;0.2-fold, suggestion an active role of XPF in repairing the base editing intermediate at <italic>HEK3</italic>.</p><p id="Par24">Knockdown of <italic>UNG</italic> increased absolute C&#x02022;G to T&#x02022;A editing efficiencies by 4.0&#x02009;&#x000b1;&#x02009;0.7-fold and 2.2&#x02009;&#x000b1;&#x02009;0.2-fold at the <italic>HEK3</italic> and <italic>RNF2</italic> sites, respectively. Meanwhile, its knockdown significantly decreased all C&#x02022;G to non-T&#x02022;A outcomes (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>). This agrees with the established role of <italic>UNG</italic> in excising the uracil intermediate. As expected, <italic>UNG</italic> knockdown also led to a major increase in the relative C&#x02022;G to T&#x02022;A outcome and decreases in all relative C&#x02022;G to non-T&#x02022;A outcomes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11b, c</xref>).</p><p id="Par25">To confirm that the observed knockdown effects were due to on-target CRISPRi knockdown, we selected one gene per pathway (<italic>UNG</italic>, <italic>ERCC4</italic>, <italic>RFWD3</italic>, and <italic>MSH2</italic>, which generally caused the greatest changes in editing profiles upon knockdown) to perform re-expression rescue experiments. For each of these four genes, we replaced the <italic>BFP</italic> gene of the reporter constructs with the cDNA of the corresponding knocked down gene to achieve stable re-expression in the appropriate CRISPRi background. Re-expression of <italic>UNG</italic>, <italic>ERCC4</italic>, <italic>RFWD3</italic>, and <italic>MSH2</italic> all fully or partially rescued the knockdown effects on all editing outcomes at both the <italic>HEK3</italic> and <italic>RNF2</italic> sites (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c, d</xref>).</p></sec><sec id="Sec9"><title>MutS&#x003b1; and UNG compete to process cytosine base editing intermediates</title><p id="Par26">To further explore how interplays between these genes influence different editing outcomes, we transfected the CRISPRi K562 stable knockdown cell lines (from Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>; in which <italic>UNG</italic>, <italic>MSH2</italic>, or <italic>MSH6</italic> were knocked down, see Methods) with either rA1-SaBE4(&#x00394;UGI), rA1-SaBE4 (which contains two copies of UGI and thus inhibits UNG during the process of base editing), or rA1-SaBE1 (which uses dSaCas9 and thus does not introduce a nick on the non-edited strand), and measured their editing outcomes at the <italic>HEK3</italic> and <italic>RNF2</italic> sites (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12a</xref>). This approach allowed us to dissect the contributions of UNG and the Cas9-induced nick to the various editing outcomes. Compared to the integrated rA1-SaBE4(&#x00394;UGI) system, transfection with rA1-SaBE4(&#x00394;UGI) demonstrated faster editing rates, with significantly higher overall editing efficiencies in 3 days (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12b, c</xref>). Moreover, we observed bystander editing at the C16 and C14 positions of the <italic>HEK3</italic> and <italic>RNF2</italic> protospacers, respectively, in addition to the C10 position. Notably, The C10 position was the only edited position when using the integrated rA1-SaBE4(&#x00394;UGI) system, and it is highly likely that multi-uracil intermediates are processed through different mechanisms. Because UGI inhibits endogenous UNG, editing with rA1-SaBE4 predominately yielded C&#x02022;G to T&#x02022;A outcomes. Editing efficiencies with rA1-SaBE1 were much lower than that of the rA1-SaBE4(&#x00394;UGI) system in the negative control cells (5.6&#x02009;&#x000b1;&#x02009;1.5-fold and 13.0&#x02009;&#x000b1;&#x02009;2.9-fold at the C10 position of <italic>HEK3</italic> and <italic>RNF2</italic> sites, respectively), highlighting the importance of the Cas9-induced nick for base editing.</p><p id="Par27">Knockdown of <italic>MSH2</italic> and <italic>MSH6</italic> in this new system with the rA1-SaBE4(&#x00394;UGI) editor did not lead to a substantial reduction in the single C&#x02022;G to T&#x02022;A editing outcome at the C10 positions (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a,&#x000a0;d</xref>). However, we will note that due to the elevated rate of editing at the C14 and C16 positions in this system, the single C&#x02022;G to T&#x02022;A outcomes could be derived from dual uracil intermediates, which adds complexity to this observation. Interestingly, the effects of <italic>MSH2</italic> or <italic>MSH6</italic> knockdown were pronounced when UNG was simultaneously inhibited via the use of the rA1-SaBE4 construct. Specifically, when editing with rA1-SaBE4, knockdown of either <italic>MSH2</italic> or <italic>MSH6</italic> led to significant decreases in the frequencies of the single C&#x02022;G to T&#x02022;A editing outcome at the C10 position at both the <italic>HEK3</italic> and <italic>RNF2</italic> sites (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a,&#x000a0;d</xref>). At the <italic>HEK3</italic> site, knockdown of <italic>MSH2</italic> or <italic>MSH6</italic> reduced the absolute editing efficiency of this outcome by 2.1&#x02009;&#x000b1;&#x02009;0.2-fold or 1.6&#x02009;&#x000b1;&#x02009;0.1-fold, respectively. At the <italic>RNF2</italic> site, knockdown of <italic>MSH2</italic> or <italic>MSH6</italic> reduced the absolute editing efficiency of this outcome by 1.9&#x02009;&#x000b1;&#x02009;0.2-fold or 1.6&#x02009;&#x000b1;&#x02009;0.3-fold, respectively. Because MutS&#x003b1; and UNG both recognize the U&#x02022;G mismatch, a potential explanation for these observations is that MutS&#x003b1; and UNG may compete for substrate recognition, with UNG having a competitive advantage. Two potential factors may synergize to give UNG such a competitive advantage over MutS&#x003b1; in the transfection system. First, multi-uracil intermediates are not optimal substrates for MutS&#x003b1;<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. In addition, multiple uracils could enhance the recruitment of UNG to the editing site.<fig id="Fig4"><label>Fig. 4</label><caption><title>Impacts of <italic>MSH2</italic>, <italic>MSH6</italic> and <italic>UNG</italic> knockdown on C&#x02022;G to T&#x02022;A outcomes in K562, HeLa, and HEK293T cells.</title><p>Cells were treated as described in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12a</xref> (K562), 13a-b (HeLa), or 14a-c (HEK293T) to induce knockdown of <italic>UNG</italic>, <italic>MSH2</italic>, or <italic>MSH6</italic>. Cells were then transfected with plasmids encoding rA1-SaBE4(&#x00394;UGI), rA1-SaBE4, or rA1-SaBE1 [rA1-dSaCas9(&#x00394;UGI)] and Sa-gRNA targeting the <italic>HEK3</italic> or <italic>RNF2</italic> loci. Three days post-transfection, transfected cells were collected by FACS and editing efficiencies at the target sites were quantified by NGS. Effects of indicated gene knockdown on C&#x02022;G to T&#x02022;A editing outcomes at the <italic>HEK3</italic> site in K562 (<bold>a</bold>), HeLa (<bold>b</bold>) and HEK293T (<bold>c</bold>) cells are shown. Effects of indicated gene knockdown on C&#x02022;G to T&#x02022;A editing outcomes at the <italic>RNF2</italic> site in K562 (<bold>d</bold>), HeLa (<bold>e</bold>) and HEK293T (<bold>f</bold>) cells are shown. Protospacer sequences are shown at the top. All C&#x02022;G to T&#x02022;A editing outcomes at these two sites are listed, and edits are highlighted in color. Vertical dashed lines mark the Cas9-induced nick position. Base editors used are labeled on the left. Tract plots display absolute frequencies of editing outcomes upon specific gene knockdown (color-coded by gene as indicated). Three negative control samples without knockdown are shown in gray, with shaded areas representing &#x000b1;2 STDs of mean. Dots show individual replicates, and tract lines show averages of <italic>n</italic>&#x02009;=&#x02009;2 (<bold>d</bold>: <italic>NCs</italic>, <italic>UNG</italic> and <italic>MSH2</italic>) or <italic>n</italic>&#x02009;=&#x02009;3 (all the rest) biological replicates. Horizontal lines show ranges of the replicates for corresponding outcomes. Heatmaps show log<sub>2</sub> (fold change) (LFC) in frequencies of editing outcomes relative to the corresponding means of negative controls. *: 1.5 &#x0003c;adjusted z-score &#x0003c;2. **: 2&#x0003c;adjusted z-score &#x0003c;3. ***: adjusted z-score &#x0003e; 3. Source data are provided as a <xref rid="MOESM6" ref-type="media">Source Data</xref> file.</p></caption><graphic xlink:href="41467_2025_59948_Fig4_HTML" id="d33e1332"/></fig></p><p id="Par28">Intriguingly, we found the effect of MutS&#x003b1; knockdown to be dependent on the target base position&#x000a0;when editing with rA1-SaBE4. At the <italic>HEK3</italic> site, knockdown of <italic>MSH2</italic> or <italic>MSH6</italic> had minimal impact on the dual C&#x02022;G to T&#x02022;A outcome frequency, but led to a 2.9&#x02009;&#x000b1;&#x02009;0.8-fold or 3.8&#x02009;&#x000b1;&#x02009;1.0-fold <italic>increase</italic> in the frequency of the single C&#x02022;G to T&#x02022;A editing outcome at the C16 position, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>). Since the C16 position is only one base pair away from the Cas9-induced nick, it may be processed productively (to produce a C&#x02022;G to T&#x02022;A outcome) via an additional pathway independent of MutS&#x003b1; recognition. When the target C is shifted two base pairs away from the nick to the C14 position, as in <italic>RNF2</italic>, knockdown of <italic>MSH2</italic> or <italic>MSH6</italic> did not result in a significant increase in the single C&#x02022;G to T&#x02022;A editing frequency at this position (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4d</xref>).</p><p id="Par29">Detecting decreases in editing efficiencies was challenging with the rA1-SaBE1 editor due to its low editing efficiencies, but we found that <italic>MSH6</italic> knockdown caused a reduction in the single C&#x02022;G to T&#x02022;A editing outcome at the C10 position at the <italic>RNF2</italic> site, from 1.9&#x02009;&#x000b1;&#x02009;0.8% to 0.8&#x02009;&#x000b1;&#x02009;0.1% (representing a 2.5&#x02009;&#x000b1;&#x02009;0.8-fold decrease, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4d</xref>).</p><p id="Par30">The effects of <italic>MSH2</italic> knockdown were further validated in both HeLa and HEK293T cells with the rA1-SaBE4(&#x00394;UGI) and rA1-SaBE4 constructs (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b, c, e, f</xref>, Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">13</xref>, <xref rid="MOESM1" ref-type="media">14</xref>; see Methods). In both cell types, we again observed that knockdown of <italic>MSH2</italic> did not (or had a minimal) impact C&#x02022;G to T&#x02022;A outcomes when using rA1-SaBE4(&#x00394;UGI). However, when editing with rA1-SaBE4, <italic>MSH2</italic> knockdown reduced the frequency of the single C&#x02022;G to T&#x02022;A editing outcome at the C10 position of <italic>HEK3</italic> by 2.8&#x02009;&#x000b1;&#x02009;0.4-fold and 1.7&#x02009;&#x000b1;&#x02009;0.1-fold in HeLa and HEK293T cells, respectively. Meanwhile, we again observed an increase in the frequency of the single C&#x02022;G to T&#x02022;A editing outcome at the C16 position of <italic>HEK3</italic> by 6.6&#x02009;&#x000b1;&#x02009;0.4-fold and 1.7&#x02009;&#x000b1;&#x02009;0.3-fold in HeLa and HEK293T cells, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b, c</xref>). At the <italic>RNF2</italic> site, the dominant outcome was the dual C&#x02022;G to T&#x02022;A outcome, which was observed with 42.0&#x02009;&#x000b1;&#x02009;0.2% and 46.8&#x02009;&#x000b1;&#x02009;2.7% efficiencies in the negative control samples in HeLa and HEK293T cells, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4e, f</xref> and Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">13e</xref>, <xref rid="MOESM1" ref-type="media">14e</xref>). This is compared to 3.3&#x02009;&#x000b1;&#x02009;0.7% in K562 cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4d</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12c</xref>). <italic>MSH2</italic> knockdown had a minimal impact on editing at this site, with the largest change being a modest reduction in the dual C&#x02022;G to T&#x02022;A editing frequency, of 1.3&#x02009;&#x000b1;&#x02009;0.2-fold and 1.4&#x02009;&#x000b1;&#x02009;0.2-fold in HeLa and HEK293T cells, respectively. We did not observe a statistically significant impact on the editing rate of the single C&#x02022;G to T&#x02022;A editing outcome at the C10 position in these cell lines. We believe this discrepancy may be due to the &#x0003e;10-fold higher editing rate of the C14 position in the HeLa and HEK293T cells compared to K562 cells.</p><p id="Par31">It is noteworthy that although HEK293T cells are deficient in MMR due to the silencing of the MutL&#x003b1; complex (a heterodimer of MLH1 and PMS2, which is responsible for generating DNA nicks following mismatch recognition), they have normal expression levels of MutS&#x003b1;<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Interestingly, editing efficiencies between HEK293T and HeLa cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">13d, e</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">14d, e</xref>) are comparable, and similar impacts of <italic>MSH2</italic> knockdown were observed across these cell lines. A possible explanation is that mismatch recognition is required, but downstream nicking by MutL&#x003b1; is dispensable for cytosine base editing when using Cas9n-derived CBEs. These findings regarding MutS&#x003b1; address gaps in our current understanding of cytosine base editing mechanisms. Previous studies in HeLa and HEK293T cells using CBEs that lack UGI did not identify MutS&#x003b1; as impacting C&#x02022;G to T&#x02022;A editing, which is consistent with these observations<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. This highlights the complexity of base editing mechanisms, which vary depending on different editors, target positions, and editing kinetics.</p></sec><sec id="Sec10"><title>RFWD3 promotes the C&#x02022;G to G&#x02022;C outcome via RPA-binding and ubiquitination</title><p id="Par32">We next repeated the same transient transfection experiments in K562, HeLa, and HEK293T cells with <italic>RFWD3</italic> knockdown and the rA1-SaBE4(&#x00394;UGI) editor. We observed consistent impacts on C&#x02022;G to G&#x02022;C editing outcomes by rA1-SaBE4(&#x00394;UGI) upon <italic>RFWD3</italic> knockdown across K562, HeLa, and HEK29T cells (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a&#x02013;f</xref>). At the <italic>RNF2</italic> site, <italic>RFWD3</italic> knockdown reduced the frequencies of all editing outcomes containing a C&#x02022;G to G&#x02022;C conversion, mirroring the impact of <italic>UNG</italic> knockdown (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d&#x02013;f</xref>). Interestingly, this included both single C&#x02022;G to G&#x02022;C editing outcomes (at the C10 and C14 positions), as well as mixed C&#x02022;G to G&#x02022;C and C&#x02022;G to T&#x02022;A or A&#x02022;T outcomes. At the <italic>HEK3</italic> site, we observed the impact of <italic>RFWD3</italic> knockdown to be dependent on the position of the target base. For example, <italic>RFWD3</italic> knockdown did not significantly affect the frequency of the single C&#x02022;G to G&#x02022;C editing outcome at the C10 position (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a&#x02013;c</xref>) in any of the three cell lines. However, it reduced the frequency of the single C&#x02022;G to G&#x02022;C editing outcome at the C16 position by 2.2&#x02009;&#x000b1;&#x02009;0.7-fold and 2.0&#x02009;&#x000b1;&#x02009;0.4-fold in K562 and HEK293T cells, respectively. To further validate these findings, we repeated these experiments in HEK293T cells with four additional sgRNAs (targeting an additional site within the <italic>RNF2</italic> gene, one site in the <italic>EMX1</italic> gene, and two sites within the <italic>HEK2</italic> locus) using the evo-BE4(&#x00394;UGI) (evoAPOBEC1 with SpCas9n) editor (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5g</xref>)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. We observed editing at a single C within the RNF2, HEK2.1, and HEK2.2 protospacers, and two Cs within the EMX1 protospacer. Across all four sites we observed robust decreases in C&#x02022;G to G&#x02022;C editing upon RFWD3, ranging from 1.6-fold to 1.8-fold.<fig id="Fig5"><label>Fig. 5</label><caption><title>Impacts of <italic>RFWD3</italic> and <italic>UNG</italic> knockdown on C&#x02022;G to G&#x02022;C outcomes in K562, HeLa, and HEK293T cells.</title><p>Cells were treated as described in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12a</xref> (K562), 13a-b (HeLa), or 14a-c (HEK293T). Shown are effects of indicated gene knockdown on the top four outcomes with C&#x02022;G to G&#x02022;C conversions at the <italic>HEK3</italic> site in K562 (<bold>a</bold>), HeLa (<bold>b</bold>) and HEK293T (<bold>c</bold>), and at the <italic>RNF2</italic> site in K562 (<bold>d</bold>), HeLa (<bold>e</bold>) and HEK293T (<bold>f</bold>). Protospacer sequences are shown at the top. Vertical dashed lines mark the Cas9-induced nick positions. Tract plots display absolute frequencies of editing outcomes upon specific gene knockdown (color-coded by gene as indicated). Three negative control samples without knockdown are shown in gray colors, with shaded areas representing &#x000b1;2 STDs of mean. Dots show individual replicates, and tract lines show averages of <italic>n</italic>&#x02009;=&#x02009;2 (<bold>d</bold>) and <italic>n</italic>&#x02009;=&#x02009;3 (all the rest) biological replicates. Horizontal lines show ranges of the replicates for corresponding outcomes. Heatmap shows log<sub>2</sub> (fold change) (LFC) in frequencies of editing outcomes relative to the mean of negative controls. *: 1.5 &#x0003c;adjusted z-score &#x0003c;2. **: 2&#x0003c;adjusted z-score &#x0003c;3. ***: adjusted z-score &#x0003e; 3. <bold>g</bold> Shown are editing efficiencies of all outcomes at five endogenous target Cs in negative control (NC) and <italic>RFWD3</italic> knockdown cell lines. The bars and the error bars represent the mean and propagation of uncertainty of standard deviation (STD) obtained from <italic>n</italic>&#x02009;=&#x02009;3 biological replicates. Heatmap shows log<sub>2</sub> (fold change) (LFC) in frequencies of editing outcomes relative to the corresponding means of negative controls. <bold>h</bold> Shown are editing efficiencies of all outcomes at two endogenous targets upon compensation of indicated RFWD3 mutants in <italic>RFWD3</italic> knockdown HEK293T cells. Negative control (NA) cells were treated identically without compensation. The bars represent the mean obtained from <italic>n</italic>&#x02009;=&#x02009;2 biological replicates. Lines show ranges of the replicates for corresponding outcomes. Heatmap shows log<sub>2</sub> (fold change) (LFC) in relative percentages of editing outcomes relative to the corresponding means of negative controls. Source data are provided as a <xref rid="MOESM6" ref-type="media">Source Data</xref> file.</p></caption><graphic xlink:href="41467_2025_59948_Fig5_HTML" id="d33e1584"/></fig></p><p id="Par33">Previous studies have demonstrated that RFWD3&#x02019;s ability to facilitate translesion synthesis depends on its RPA-binding and ubiquitination activities<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. To determine whether RFWD3&#x02019;s involvement in the C&#x02022;G to G&#x02022;C editing outcome also relies on these functions, we co-transfected the RFWD3 knockdown HEK293T cells with plasmids encoding evo-BE4(&#x00394;UGI), sgRNA targeting either the <italic>RNF2</italic> or <italic>HEK2.1</italic> protospacers, and one of the following RFWD3 variants: wild-type RFWD3, RFWD3<sup>C315A</sup>, which lacks ubiquitination function, or RFWD3<sup>I639K</sup>, which lacks RPA-binding ability (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5h</xref>). Compensation with wild-type RFWD3 substantially increased relative C&#x02022;G to G&#x02022;C editing efficiencies at both the <italic>RNF2</italic> and <italic>HEK2.1</italic> sites, but not the absolute C&#x02022;G to G&#x02022;C editing levels, which remained within error of the <italic>RFWD3</italic> knockdown samples. Compensation with RFWD3<sup>C315A</sup> decreased the absolute C&#x02022;G to G&#x02022;C editing efficiencies by 2.5&#x02009;&#x000b1;&#x02009;0.8-fold and 1.3&#x02009;&#x000b1;&#x02009;0.1-fold at the <italic>RNF2</italic> and <italic>HEK2.1</italic> sites, respectively. Meanwhile, compensation with RFWD3<sup>I639K</sup> did not significantly impact either the absolute or relative C&#x02022;G to G&#x02022;C editing efficiencies at either site. Notably, compared to RFWD3<sup>I639K</sup>, compensation with wild-type RFWD3 decreased absolute C&#x02022;G to T&#x02022;A and C&#x02022;G to A&#x02022;T editing efficiencies at both sites. A mechanism consistent with these data is that localization of RFWD3 to the editing site may facilitate repair of the U&#x02022;G intermediate to either G&#x02022;C or back to C&#x02022;G. Disruption of RFWD3&#x02019;s ubiquitination function via the RFWD3<sup>C315A</sup> mutant was the only condition that decreased absolute C&#x02022;G to G&#x02022;C editing efficiencies, suggesting this may have resulted in preferential conversion of the intermediate toward other outcomes.</p><p id="Par34">In an effort to explore strategies that specifically enhance the C&#x02022;G to G&#x02022;C outcome, we co-transfected wild-type HEK293T cells with plasmids encoding evo-BE4(&#x00394;UGI), sgRNA targeting either the <italic>RNF2</italic> or <italic>HEK2.1</italic> protospacers, and one of the three RFWD3 variants (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">14g</xref>). We found that none of these overexpression strategies caused any significant changes in relative C&#x02022;G to G&#x02022;C editing efficiencies and in fact consistently caused a reduction in absolute editing efficiencies. This may be due to the large size of this additional gene (the protein product is 774 amino acids) causing a reduction in expression or cell fitness.</p></sec><sec id="Sec11"><title>Competition and cooperation of multiple genes shape mixed editing outcomes</title><p id="Par35">We additionally examined the effects of <italic>POLD1</italic>, <italic>ERCC4</italic>, or <italic>LIG3</italic> knockdown on editing efficiencies by rA1-SaBE4(&#x00394;UGI), rA1-SaBE4, and rA1-SaBE1 at the <italic>HEK3</italic> and <italic>RNF2</italic> sites in K562 cells. These data, along with that from <italic>UNG</italic>, <italic>MSH2</italic>, <italic>MSH6</italic>, and <italic>RFWD3</italic> are shown in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a, b</xref> for all editing outcomes, including mixed C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C dual edits. We observed high toxicity following transfection of cells in which <italic>LIG3</italic> or <italic>POLD1</italic> was knocked down, presumably due to the essential roles these genes play in maintaining genomic stability in the face of DNA damage. Consequently, we observed minimal impact of <italic>POLD1</italic> knockdown on editing outcomes, except for reductions in the frequence of dual editing outcomes containing either two C&#x02022;G to T&#x02022;A edits or one C&#x02022;G to T&#x02022;A edit combined with one C&#x02022;G to G&#x02022;C edit when using rA1-SaBE4(&#x00394;UGI) at the <italic>RNF2</italic> site. Furthermore, <italic>LIG3</italic> knockdown did not cause any statistically significant changes in editing outcomes when base editors were transfected, in contrast to the integrated editing system. <italic>ERCC4</italic> knockdown increased the frequency of certain dual editing outcomes when using rA1-SaBE4(&#x00394;UGI) at both sites. Additionally, we observed <italic>ERCC4</italic> knockdown to consistently increase all editing outcomes when using rA1-SaBE1, indicating a potential additional role for this gene in facilitating mutational conversions in the absence of the Cas9-induced nick.<fig id="Fig6"><label>Fig. 6</label><caption><title>Competition and cooperation of multiple genes shape base editing outcomes.</title><p>Effects of indicated gene knockdown on editing outcomes at the <italic>HEK3</italic> (<bold>a</bold>) and <italic>RNF2</italic> (<bold>b</bold>) sites in K562 cells. Protospacer sequences are shown at the top, and base editors used are labeled on the left. The top eight, five, and three editing outcomes for rA1-SaBE4(&#x00394;UGI), rA1-SaBE4, and rA1-SaBE1 [rA1-dSaCas9(&#x00394;UGI)] are listed, respectively. Tract plots display absolute frequencies of editing outcomes upon specific gene knockdown (color-coded by gene as indicated). Three negative control samples without knockdown are shown in gray colors, with shaded areas representing &#x000b1;2 STDs of mean. Dots show individual replicates, and tract lines show averages of <italic>n</italic>&#x02009;=&#x02009;2 (<bold>b</bold>: NCs, <italic>UNG</italic>, <italic>MSH2</italic>, <italic>LIG3</italic>, <italic>RFWD3</italic>, <italic>ERCC4</italic>) and <italic>n</italic>&#x02009;=&#x02009;3 (all the rest) biological replicates. Horizontal lines show ranges of the replicates for corresponding outcomes. Heatmap shows log<sub>2</sub> (fold change) (LFC) in frequencies of editing outcomes relative to the corresponding means of negative controls. *: 1.5 &#x0003c;adjusted z-score &#x0003c;2. **: 2&#x0003c;adjusted z-score &#x0003c;3. ***: adjusted z-score &#x0003e; 3. (<bold>c</bold>) Proposed mechanisms of cytosine base editing. Competition and cooperation among indicated genes influence base editing outcomes. Dash lines indicate the effects of those genes were only observed in the integrated rA1-SaBE4(&#x00394;UGI) system where only one target C was edited. Created in BioRender. Gu, S. (2025) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/untq2zw">https://BioRender.com/untq2zw</ext-link>. Source data are provided as a <xref rid="MOESM6" ref-type="media">Source Data</xref> file.</p></caption><graphic xlink:href="41467_2025_59948_Fig6_HTML" id="d33e1762"/></fig></p><p id="Par36">When analyzing mixed editing outcomes, we observed that their editing frequencies were often influenced by multiple repair factors. For example, at the <italic>HEK3</italic> site, the dual T10/G16 outcome (observed only with rA1-SaBE4(&#x00394;UGI)) was decreased by knockdown of <italic>UNG</italic> or <italic>RFWD3</italic>, but increased by knockdown of <italic>ERCC4</italic>. At the <italic>RNF2</italic> site, the T10/G14 edit (observed only with rA1-SaBE4(&#x00394;UGI)) was decreased by knockdown of <italic>RFWD3</italic> but increased by <italic>ERCC4</italic> knockdown. Meanwhile, the dual T10/T14 edit was decreased by knockdown of <italic>MSH6</italic> but increased by <italic>UNG</italic> knockdown. When UNG was inhibited by UGI (when using the rA1-SaBE4 construct), MutS&#x003b1; emerged as the primary factor influencing C&#x02022;G to T&#x02022;A conversions. In the absence of the Cas9-induced nick (when using the rA1-SaBE1 construct), <italic>UNG</italic> knockdown consistently increased C&#x02022;G to T&#x02022;A outcomes, while <italic>ERCC4</italic> knockdown increased all outcomes.</p><p id="Par37">We then repeated our HeLa cell knockdown experiments with <italic>LIG3</italic> and <italic>ERCC4</italic> (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">15</xref>). In HeLa cells, UNG exhibited a significantly more dominant role than in K562 cells, as reflected by the greater fold changes in outcomes following <italic>UNG</italic> knockdown. Knockdown of <italic>MSH2</italic> did not significantly impact C&#x02022;G to T&#x02022;A outcomes at either locus when using rA1-SaBE4(&#x00394;UGI), but was the only gene to demonstrate a significant impact on editing outcomes when UNG is inhibited by rA1-SaBE4 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">15a</xref>). <italic>RFWD3</italic> knockdown resulted in similar effects in both HeLa and K562 cells. However, <italic>ERCC4</italic> knockdown did not produce the same significant increase in many of the editing outcomes in HeLa cells as was observed in K562 cells, potentially due to the near saturated editing efficiencies in HeLa cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">13d, e</xref>).</p></sec></sec><sec id="Sec12" sec-type="discussion"><title>Discussion</title><p id="Par38">Here, we have identified through CRISPRi screens several genes that regulate cytosine base editing outcomes. Our data suggest that the unique mutagenic intermediate of cytosine base editing is recognized and processed by multiple genes, and the genetic landscapes governing different outcomes vary depending on the targeting sequences, editing kinetics, and possibly cell type. Notably, our data suggest that intermediates involving multiple uracils are processed via a different mechanism than single uracil intermediates.</p><p id="Par39">A mechanism that is consistent with our observations is one in which UNG and the MutS&#x003b1; complex (the MSH2/MSH6 heterodimer) compete to recognize the U&#x02022;G intermediate, with UNG generally dominating this competition. While recognition by UNG facilitates C&#x02022;G to non-T&#x02022;A outcomes, recognition by MutS&#x003b1; promotes the C&#x02022;G to T&#x02022;A outcome (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>)<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. Natively, MutS&#x003b1; recognition initiates downstream MMR processes resulting in replacement of the DNA strand that is nicked by MutL&#x003b1;<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. In cytosine base editing, this strand discrimination signal is potentially provided by the Cas9-induced nick on the non-edited strand. Hence, replacement of the non-edited strand would facilitate the C&#x02022;G to T&#x02022;A outcome. Under conditions where only one target C is edited, we observed LIG3 to inhibit strand replacement, potentially by sealing the Cas9-induced nick, and POLD1 to facilitate strand replacement, likely through its role in DNA synthesis.</p><p id="Par40">Excision of uracil by UNG generates an abasic site, which can be processed by downstream BER to achieve the fully repaired outcome (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>)<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Alternatively, DNA synthesis may occur before BER-mediated processing of the abasic site, which can lead to the activation of translesion synthesis due to stalling of replicative polymerases at the abasic site<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Our data are consistent with a mechanism in which RFWD3 plays an important role in facilitating the translesion synthesis pathway that specifically leads to the C&#x02022;G to G&#x02022;C outcome. When replication stalls, ssDNA becomes exposed and is subsequently bound by RPA. RFWD3 is recruited to the site of stalled replication through its interaction with RPA and then initiates a series of ubiquitylation reactions of RPA and nearby proteins. This process eventually leads to mono-ubiquitylation of PCNA, which promotes the recruitment of Y-family error-prone polymerases to carry out DNA synthesis over the replication-blocking lesion<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. We show both the RPA-binding and ubiquitylation activities of RFWD3 are essential for its role in facilitating the C&#x02022;G to G&#x02022;C outcome. However, the specific error-prone polymerase responsible for incorporating a deoxycytidine across the abasic site in cytosine base editing remains unclear, as knockdown of either <italic>REV1</italic> or <italic>POLH</italic> only marginally reduced C&#x02022;G to G&#x02022;C editing efficiencies (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>). This is consistent with other studies that attempted to identify the error-prone polymerase responsible for the C&#x02022;G to G&#x02022;C outcome<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Future studies that perturb multiple genes simultaneously may be required to provide further insights into this process<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>.</p><p id="Par41">Studies have shown that XPF (encoded by <italic>ERCC4</italic>) is a structure-specific endonuclease that specifically cleaves at the junction of double- and single-stranded DNA of 3&#x02019; flap structures (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. In the case of cytosine base editing, a 3&#x02019; flap can arise from displacement of the newly synthesized strand by the old non-edited strand via flap equilibrium. Cleavage of the newly synthesized strand abolishes mutation formation, which is consistent with the increase in certain editing outcomes at the two endogenous sites upon <italic>ERCC4</italic> knockdown (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a, b</xref>).</p><p id="Par42">While DNA mismatch repair has been hypothesized to participate in base editing since its invention, this has not been experimentally validated previously<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Furthermore, we identified additional DNA repair genes that were previously not known to resolve the cytosine base editing intermediate, and discovered the role of RFWD3 in specifically mediating the C&#x02022;G to G&#x02022;C outcome. Overall, this study sheds light on several key aspects of the cellular processing of the unique DNA damage intermediate leveraged in cytosine base editing.</p></sec><sec id="Sec13"><title>Methods</title><sec id="Sec14"><title>Plasmid design and cloning</title><p id="Par43">A full list of all plasmids used in this study is included in Supplementary Data&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>, <xref rid="MOESM1" ref-type="media">5</xref>. The pMH0001 (dCas9-BFP-KRAB) was obtained from Addgene (#85969). All cloning primers were obtained from Integrated DNA Technologies (IDT). The dCas9-KRAB-MeCP2-P2A-mCherry lentiviral vector (pSG231) was derived from dCas9-KRAB-MeCP2 (Addgene, 110821). First, an intermediate plasmid was generated in which a P2A-mCherry cassette was added to the end of the dCas9-KRAB-MeCP2 insert. USER cloning was then used to construct pSG231, in which the dCas9-BFP-KRAB insert in pMH0001 was replaced with dCas9-KRAB-MeCP2-P2A-mCherry<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.</p><p id="Par44">All rA1-SaBE4(<inline-formula id="IEq2"><alternatives><tex-math id="d33e1944">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta$$\end{document}</tex-math><mml:math id="d33e1949"><mml:mi mathvariant="normal">&#x00394;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq2.gif"/></alternatives></inline-formula>UGI) plasmids were derived from SaBE4 (Addgene, #100805). The UGI portion of SaBE4 was replaced with a P2A-miRFP670 cassette to construct pSG199 (the rA1-SaBE4(<inline-formula id="IEq3"><alternatives><tex-math id="d33e1954">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta$$\end{document}</tex-math><mml:math id="d33e1959"><mml:mi mathvariant="normal">&#x00394;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq2.gif"/></alternatives></inline-formula>UGI)) variant with rAPOBEC1). eA3A and RrA3F templates were obtained from p2T-eA3Amax (Addgene, 152999) and pCMV-BE4-RrA3F (Addgene, 138340), respectively. The rA1 portion of pSG199 was replaced with eA3A or RrA3F via USER cloning to construct pSG200 and pSG201, respectively. The backbone of the rA1-SaBE4(&#x00394;UGI) PiggyBac transposon plasmid, pSG236, was adopted from PB-TRE-dCas9-VPR (Addgene, #63800). rA1-SaBE4(<inline-formula id="IEq4"><alternatives><tex-math id="d33e1964">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta$$\end{document}</tex-math><mml:math id="d33e1969"><mml:mi mathvariant="normal">&#x00394;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq2.gif"/></alternatives></inline-formula>UGI) was assembled into the PiggyBac backbone with USER cloning to produce pSG236.</p><p id="Par45">The backbone of both reporter vectors was adopted from pU6-sgRNA EF1&#x003b1;-puro-T2A-BFP (Addgene, #60955). A hU6-2xBsmBI-Sa-sgRNA cassette was inserted in between the pU6-sgRNA cassette and EF1&#x003b1; promotor, and the wild-type BFP was replaced with the BFP reporter variant by USER cloning to construct pSG297. To construct the lentiviral C&#x02022;G to T&#x02022;A reporter vector pSG298, the targeting spacer sequence was introduced into the Sa-sgRNA expression cassette via golden gate cloning using BsmBI-v2 (R0739L, NEB)<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. To construct the lentiviral C&#x02022;G to G&#x02022;C reporter vector pSG299, the entire EF1&#x003b1;-puro-T2A-BFP cassette in pSG297 was replaced with the C&#x02022;G to G&#x02022;C reporter (dGFP-2bp-P2A-mCherry) and EF1&#x003b1;-puro cassettes, followed by introduction of the targeting spacer sequence to the Sa-sgRNA expression cassette by BsmBI golden gate cloning. For validation at BFP/dGFP reporter sites, individual CRISPRi Sp-sgRNAs nominated from screens were cloned into the corresponding reporter vectors (pSG298 or pSG299) via BstXI/BlpI (BstXI: R0113L, BlpI: R0585L, NEB) restriction enzyme cloning to produce single CRISPRi Sp-sgRNA vectors (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref>). For validation at endogenous sites, CRISPRi Sp-sgRNAs were first cloned into pSG297 by BstXI/BlpI restriction enzyme cloning, followed by incorporation of the spacer sequences of Sa-sgRNA targeting endogenous sites by BsmBI golden gate assembly (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref>). For cDNA re-expression experiments, the BFP portion of these plasmids was replaced with the corresponding cDNA sequence (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">6</xref>). The cDNA of <italic>UNG</italic> was obtained from reverse transcription of mRNA in HEK293T. cDNA sequences of <italic>RFWD3</italic>, <italic>ERCC4</italic> and <italic>MSH2</italic> were ordered from GenScript (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">6</xref>).</p><p id="Par46">Dual sgRNA vectors used in generating HeLa and HEK293T stable knockdown cell lines were cloned according to an established protocol<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Briefly, oligos were designed containing two spacer sequences (ps1 and ps2) separated by 2xBsmBI recognition sites with BstXI and BlpI sites at the 5&#x02019;- and 3&#x02019;-ends, respectively (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">6</xref>). Spacer sequences for each gene are listed in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref>. Oligos were ordered (IDT) and cloned into the pSG942 lentiviral backbone (mU6-BstXI/BlpI-UCOE-EF1&#x003b1;-puro-T2A-EGFP) via BstXI/BlpI restriction enzyme cloning. Next, the &#x0201c;drop-in&#x0201d; sequence containing the Sp-sgRNA backbone and hU6 promoter (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref>) was inserted in between the two spacer sequences by BsmBI golden gate cloning to produce the full dual sgRNA expression vector (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref>).</p></sec><sec id="Sec15"><title>Cell culture and cell line construction</title><p id="Par47">All cell lines were cultured at 37&#x02009;&#x000b0;C with 5% CO<sub>2</sub> and 95% relative humidity. HEK293T (ATCC, CRL-1573) and HeLa cells (ATCC, CRL-3216) were cultured in Dulbecco&#x02019;s Modified Eagle Medium (DMEM) supplemented with GlutaMAX (10566-024, Thermo Fisher) and 10% (v/v) fetal bovine serum (10437-028, Thermo Fisher). K562 cells (ATCC, CCL-243) were grown in Roswell Park Memorial Institute (RPMI) 1640 Medium (11875-119, Thermo Fisher) supplemented with 10% (v/v) fetal bovine serum and 1% penicillin/streptomycin (15140122, Gibco). All cell lines were authenticated by the supplier (ATCC) with short tandem repeat (STR) profiling and tested negative for mycoplasma with Mycostrip (InvivoGen, rep-mys-10) every two months.</p><p id="Par48">To construct the CRISPRi-expressing cell line for the C&#x02022;G to T&#x02022;A screen, wild-type K562 cells were transduced with the dCas9-KRAB-MeCP2-P2A-mCherry lentiviral vector (pSG231) described above. To construct the CRISPRi-expressing cell line for the C&#x02022;G to G&#x02022;C screen, wild-type K562 cells were transduced with the dCas9-BFP-KRAB lentiviral vector (pMH0001). These transductions were performed as described below. Pure polyclonal populations of each CRISPRi-expressing cell line were then generated by sorting the transduced cells on a BD FACS Aria II for the top 50% of mCherry or BFP signal, respectively.</p><p id="Par49">Doxycycline-inducible rA1-SaBE4(&#x00394;UGI) expression and hygromycin resistance cassettes (pSG236) were then incorporated into each CRISPRi-expressing cell line via PiggyBac transposition. Briefly, 100&#x02009;ng transposon vector (pSG236) and 20&#x02009;ng PiggyBac transposase vector (PB210PA-1, SBI) were co-transfected into 20,000 CRISPRi-expressing K562 cells using Lipofectamine 2000 (11668027, Invitrogen). Two days after transfection, cells with stable integration were selected by a 2-week, 200&#x02009;&#x000b5;g/ml hygromycin treatment.</p><p id="Par50">To construct CRISPRi HeLa cells, wild-type HeLa cells were transduced with the dCas9-BFP-KRAB lentiviral vector (pMH0001) at an infection rate of approximately 30%. Pure polyclonal population of CRISPRi-expressing cells were collected by sorting the transduced cells on a BD FACS Aria II for the top 50% of BFP signal. A second sort was performed after a 7-day expansion of the collected cells from the first sort to ensure a&#x02009;&#x0003e;&#x02009;90% BFP+ population.</p></sec><sec id="Sec16"><title>Evaluation of different deaminases and validation of reporter constructs</title><p id="Par51">HEK293T cells were seeded at 100,000 cells/well in 250&#x02009;&#x000b5;L media in a 48-well plate and transfected four hours later with a 25&#x02009;&#x000b5;L DNA/Lipofectamine 2000 mixture. This mixture was prepared by diluting 950&#x02009;ng of a DNA mixture (described below) to 12.5&#x02009;&#x000b5;L total volume with Opti-MEM reduced-serum medium (31985-070, Thermo Fisher) and adding this to a mixture of 1.5&#x02009;&#x000b5;L Lipofectamine 2000 and 11&#x02009;&#x000b5;L Opti-MEM. The DNA mixture was comprised of 500&#x02009;ng of a SaCas9-BE4(<inline-formula id="IEq5"><alternatives><tex-math id="d33e2039">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta$$\end{document}</tex-math><mml:math id="d33e2044"><mml:mi mathvariant="normal">&#x00394;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq2.gif"/></alternatives></inline-formula>UGI) vector with one of the rAPOBEC1 (pSG199), eA3A (pSG200), or RrA3F (pSG201) deaminases, 300&#x02009;ng of either the C&#x02022;G to T&#x02022;A (pSG139) or C&#x02022;G to G&#x02022;C transient reporter vector (pSG154), and 150&#x02009;ng of a sgRNA vector (pSG157 or pSG158 for the C&#x02022;G to T&#x02022;A reporter and C&#x02022;G to G&#x02022;C reporter, respectively). 72&#x02009;h post-transfection, cells were analyzed by flow cytometry using a BD LSRFortessaX20 for either BFP to GFP conversion (for the C&#x02022;G to T&#x02022;A reporter) or GFP turn-on (for the C&#x02022;G to G&#x02022;C reporter). A total of 10,000 events were analyzed in Flowjo v10.9 for each sample to calculate conversion or turn-on rates.</p></sec><sec id="Sec17"><title>CRISPRi library design and construction</title><p id="Par52">The 12,318 sgRNA CRISPRi library was adapted from a previously published library (Richardson et al.)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. In Richardson&#x02019;s library, a set of 2015 genes enriched for those involved in DNA metabolic processes and the cellular response to DNA damage was curated (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">1</xref>). The targeting sgRNAs and 2243 non-targeting control sgRNAs from this library originated from hCRISPRi-v2 (Horlbeck et al., 2016)<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. The CRISPRi sgRNA library was constructed using the protocol available at <ext-link ext-link-type="uri" xlink:href="https://weissman.wi.mit.edu/crispr/">https://weissman.wi.mit.edu/crispr/</ext-link>. Briefly, an oligonucleotide pool containing these spacer sequences was synthesized by Agilent. Primer binding sites, BstXI and BlpI recognition sites, and the appropriate overhang sequence for cloning into the reporter vectors, were appended to the 5&#x02019; and 3&#x02019; ends of each spacer sequence (Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">6</xref>). The oligonucleotide pool was amplified by PCR using Phusion DNA Green High-Fidelity Polymerase (F534L, Thermo Fisher), purified with the MinElute PCR purification kit (28004, QIAGEN), and digested with BstXI and BlpI. The digested oligonucleotide library was then isolated by polyacrylamide gel electrophoresis followed by ethanol precipitation. The C&#x02022;G to T&#x02022;A (pSG298) and C&#x02022;G to G&#x02022;C reporter vectors (pSG299) were also digested with BstXI and BlpI and purified by agarose gel electrophoresis and the QIAquick gel extraction kit (28704). The digested spacer library was then ligated into both digested reporter vectors by incubating the two DNA pieces with an insert to backbone ratio of 2:1 at 16&#x02009;&#x000b0;C for 16&#x02009;h with T4 DNA ligase (M0202, New England Biolabs). 50&#x02009;ng of the ligation mixture was then electroporated into 50&#x02009;&#x003bc;l of NEB 10-beta cells (C3019, New England Biolabs). Greater than 300x library coverage was achieved at transformation for both the C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C library by performing at least 5 electroporations. Cells were grown in 2XYT media (200&#x02009;mL) supplemented with 100&#x02009;&#x000b5;g/ml carbenicillin at 37&#x02009;&#x000b0;C for 16&#x02009;h, after which the library-containing plasmids were purified using the ZymoPURE II plasmid midiprep kit (D4201, Zymo).</p></sec><sec id="Sec18"><title>Lentivirus production</title><p id="Par53">For small-scale viral production when creating cell lines, 3&#x02009;<inline-formula id="IEq6"><alternatives><tex-math id="d33e2075">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2080"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>5</sup> HEK293T cells per well were seeded in 2&#x02009;mL of media in 6-well plates and transfected 24&#x02009;h later with a 300&#x02009;&#x000b5;L DNA/TransIT-LT1 (MIR2306, Mirus) solution. This mixture was prepared by diluting a DNA mixture consisting of 165&#x02009;ng pMD2.G (12259, Addgene), 1350&#x02009;ng pCMV-delta-R8.2 (12263, Addgene), 100&#x02009;ng pMax_GFP, and 1500&#x02009;ng transfer plasmid to 292.5&#x02009;&#x000b5;L total volume with Opti-MEM. Then, 7.5&#x02009;&#x000b5;L TransIT-LT1 was added to this mixture. These DNA/TransIT-LT1 solutions were incubated at room temperature for 15&#x02009;min and added dropwise into each well. Viral supernatant was harvested 72&#x02009;h after transfection and filtered through a 0.45 <inline-formula id="IEq7"><alternatives><tex-math id="d33e2086">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2091"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> m PES syringe filter (725-2545, Thermo Scientific).</p><p id="Par54">To perform large-scale viral productions for the pooled CRISPRi screens, 3&#x02009;<inline-formula id="IEq8"><alternatives><tex-math id="d33e2098">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2103"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>6</sup> HEK293T cells per 15&#x02009;cm<sup>2</sup> dish were seeded in 30&#x02009;mL of medium and then transfected 24&#x02009;h later with a 1&#x02009;mL DNA/TransIT-LT1 solution. This mixture was prepared by diluting a DNA mixture consisting of 2 <inline-formula id="IEq9"><alternatives><tex-math id="d33e2111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2116"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g pMD2.G, 16 <inline-formula id="IEq10"><alternatives><tex-math id="d33e2121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2126"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g pCMV-delta-R8.2, 2 <inline-formula id="IEq11"><alternatives><tex-math id="d33e2132">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2137"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g pMax_GFP, and 16 <inline-formula id="IEq12"><alternatives><tex-math id="d33e2142">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2147"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g transfer plasmid (containing the CRISPRi sgRNA library) to 1000&#x02009;&#x000b5;L total volume with Opti-MEM. Then, 48&#x02009;&#x000b5;L TransIT-LT1 was added to this mixture. These DNA/TransIT-LT1 solutions were incubated at room temperature for 15&#x02009;min and added dropwise into each dish. 24&#x02009;h post-transfection, 60&#x02009;&#x000b5;L of viral boost (VB100, Alstembio) was added to each dish according to the manufacturer&#x02019;s instructions. 72&#x02009;h post-transfection, the viral supernatant of all dishes with the same library was pooled and filtered through a 0.45 <inline-formula id="IEq13"><alternatives><tex-math id="d33e2152">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2157"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> m PES vacuum filter.</p></sec><sec id="Sec19"><title>Lentiviral titering</title><p id="Par55">To determine the lentiviral titer for transductions of pooled CRISPRi sgRNA libraries, 12&#x02009;<inline-formula id="IEq14"><alternatives><tex-math id="d33e2166">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2171"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>6</sup> cells of the appropriate K562 cell line were plated in 2&#x02009;mL media per well in 6 well plates and transduced with 0, 1&#x02009;ml, 3&#x02009;ml, or 6&#x02009;ml virus supplemented with 8 <inline-formula id="IEq15"><alternatives><tex-math id="d33e2177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2182"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml polybrene (TR-1003-G, Sigma). The plates were centrifuged at 1000<inline-formula id="IEq16"><alternatives><tex-math id="d33e2187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2192"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> g for 2&#x02009;h at 33&#x02009;&#x000b0;C. Virus-containing media was then aspirated, and cells were resuspended at 0.5&#x02009;<inline-formula id="IEq17"><alternatives><tex-math id="d33e2196">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2201"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>6</sup> cells/ml in fresh media. Cells infected with the C&#x02022;G to T&#x02022;A reporter vector were analyzed for BFP fluorescence 2 days after transduction using flow cytometry on a BD LSRFortessa X20. Cells infected with the C&#x02022;G to G&#x02022;C reporter vector were split equally into twin wells in a 6 well-plate and 2.5 <inline-formula id="IEq18"><alternatives><tex-math id="d33e2208">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2213"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml puromycin was applied to one of the two wells for 3 days. On day 3, the number of cells in both wells were counted to calculate viability. A viral dose resulting in around 10% infection rate was then chosen to perform the pooled screens.</p></sec><sec id="Sec20"><title>CRISPRi pooled screens</title><p id="Par56">For both the C&#x02022;G to T&#x02022;A and C&#x02022;G to G&#x02022;C screens, cells were transduced in 2 biological replicates with their corresponding lentiviral library. For both screen, transductions were performed at a low multiplicity of infection (MOI&#x02009;&#x0003c;&#x02009;0.1), using 2&#x02009;<inline-formula id="IEq19"><alternatives><tex-math id="d33e2222">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2227"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>8</sup> cells to ensure a representation of at least 500<inline-formula id="IEq20"><alternatives><tex-math id="d33e2233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2238"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> coverage for each sgRNA after transduction. 1.2&#x02009;<inline-formula id="IEq21"><alternatives><tex-math id="d33e2242">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2247"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>7</sup> cells were plated per well in 6-well plates to give a density of 2&#x02009;<inline-formula id="IEq22"><alternatives><tex-math id="d33e2254">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2259"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>6</sup> cells/ml with virus-containing media and 8 <inline-formula id="IEq23"><alternatives><tex-math id="d33e2265">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2270"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml polybrene. Plates were centrifuged at 1000<inline-formula id="IEq24"><alternatives><tex-math id="d33e2275">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2280"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> g for 2&#x02009;h at 33&#x02009;&#x000b0;C. After centrifugation, cells were pooled, spun down again at 300<inline-formula id="IEq25"><alternatives><tex-math id="d33e2284">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2289"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> g for 10&#x02009;minutes and resuspended in fresh RPMI media to a density of 0.5&#x02009;<inline-formula id="IEq26"><alternatives><tex-math id="d33e2293">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2298"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>6</sup> cells/ml. Two days post-transduction, 2.5 <inline-formula id="IEq27"><alternatives><tex-math id="d33e2305">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2310"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml puromycin was added to the media, and cells were maintained for another 3 days. The day on which puromycin selection was concluded was designated as day 0 for the screens. To perform the screens, on day 0 cells were resuspended into fresh RPMI media to a density of 5&#x02009;<inline-formula id="IEq28"><alternatives><tex-math id="d33e2315">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2320"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>5</sup> cells/ml and then split into an experimental arm and a control arm, each containing at least 1.5&#x02009;<inline-formula id="IEq29"><alternatives><tex-math id="d33e2326">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2331"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>7</sup> cells (&#x0003e;1000<inline-formula id="IEq30"><alternatives><tex-math id="d33e2338">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2343"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> sgRNA coverage). An additional 1.5&#x02009;<inline-formula id="IEq31"><alternatives><tex-math id="d33e2347">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2352"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>7</sup> cells were harvested for genomic DNA extraction using the Nucleospin Blood L kit (740954.20, Macherey-Nagel) to serve as a control on day 0. The cells in the experimental arm were treated with 100&#x02009;ng/ml doxycycline (MP219504410, MP Biomedicals), while cells in the control arm continued to be cultured without doxycycline. Both arms were passaged every two days while maintaining at least 1000<inline-formula id="IEq32"><alternatives><tex-math id="d33e2358">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2363"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> sgRNA coverage. On day 13, 3.0&#x02009;<inline-formula id="IEq33"><alternatives><tex-math id="d33e2367">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2372"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>7</sup> cells from the experimental arm (representing &#x0003e;2000x sgRNA coverage) were sorted into populations of interest (GFP+ population for the C&#x02022;G to T&#x02022;A screen, GFP&#x02009;+&#x02009;/ mCherry- and GFP-/mCherry+ populations for the C&#x02022;G to G&#x02022;C screen) on a BD FACSAria II or Fusion. An additional 1.5&#x02009;<inline-formula id="IEq34"><alternatives><tex-math id="d33e2379">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2384"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>7</sup> cells from the experimental arm and 1.5&#x02009;<inline-formula id="IEq35"><alternatives><tex-math id="d33e2390">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2395"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>7</sup> cells (representing &#x0003e;1000x sgRNA coverage each) from the control arm were also collected on day 13 to serve as unsorted controls. The genomic DNA from all collected populations was then extracted using the Nucleospin blood L kit.</p></sec><sec id="Sec21"><title>CRISPRi pooled screen library sequencing</title><p id="Par57">To quantify the base editing efficiencies of the screens, 5% of the genomic DNA collected from each population was used to amplify the <italic>BFP</italic> (C&#x02022;G to T&#x02022;A screen) or <italic>dGFP</italic> (C&#x02022;G to G&#x02022;C screen) locus. The remainder of the genomic DNA from each population was used in entirety to amplify the CRISPRi sgRNA region. Amplification primer sequences are provided in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">6</xref>. Round 1 PCRs were set up using Phusion DNA Green High-Fidelity Polymerase (F534, ThermoFisher Scientific) with 5 <inline-formula id="IEq36"><alternatives><tex-math id="d33e2414">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2419"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g of genomic DNA per 100ul reaction volume. These reactions also contained GC buffer, 3% DMSO and 1 <inline-formula id="IEq37"><alternatives><tex-math id="d33e2424">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2429"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula>M each primer. The thermocycler was set with the following program: 1 cycle of 98&#x02009;&#x000b0;C for 2&#x02009;min, 23 to 26 cycles of 98&#x02009;&#x000b0;C for 30&#x02009;s, 60&#x02009;&#x000b0;C for 30&#x02009;s and 72&#x02009;&#x000b0;C for 20&#x02009;s, and 1 cycle of 72&#x02009;&#x000b0;C for 10&#x02009;min followed by holding at 4&#x02009;&#x000b0;C. PCRs from the same population were pooled and cleaned up using the QIAquick PCR purification kit (QIAGEN), and target bands were further isolated by gel extraction. Round 2 PCRs were conducted using 10&#x02009;ng of purified DNA from round 1 PCRs per 100ul reaction volume to append unique sequencing barcodes to samples from different populations. Round 2 PCRs contained HF buffer and 0.125 <inline-formula id="IEq38"><alternatives><tex-math id="d33e2435">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2440"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> M of each primer, and were run on a thermocycler with the following program: 1 cycle of 98&#x02009;&#x000b0;C for 30&#x02009;s, 10 cycles of 98&#x02009;&#x000b0;C for 15&#x02009;s, 65&#x02009;&#x000b0;C for 30&#x02009;s and 72&#x02009;&#x000b0;C for 15&#x02009;s, and 1 cycle of 72&#x02009;&#x000b0;C for 10&#x02009;min followed by holding at 4&#x02009;&#x000b0;C. Samples were pooled, purified by gel extraction, and then quantified by a Qubit using the dsDNA HS assay kit (Q32854, Thermo Fisher). Sequencing was performed on an Illumina MiniSeq using the high output reagent kit (FC-420-1002) with 10% spike-in of PhiX. Enough sequencing reads were assigned to each population to ensure at least 200<inline-formula id="IEq39"><alternatives><tex-math id="d33e2445">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2450"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula> reads per sgRNA.</p></sec><sec id="Sec22"><title>CRISPRi screen data analysis</title><p id="Par58">CRISPRi pooled screen data analysis was performed using MAGeCK RRA (v0.5.9.4)<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. Briefly, reads from different samples were median-normalized, and zero-count sgRNAs were removed. Gene phenotype was defined as the median log<sub>2</sub> fold change of the 5 target CRISPRi sgRNAs, and <italic>P</italic> values were computed based on the negative binomial model using a modified robust ranking aggregation algorithm. For gene ontology enrichment analysis, genes with -log<sub>2</sub>(<italic>P</italic>) values greater than 1.5 were searched for enriched gene ontology biological processes (GOBP) using MAGeCKFlute.</p></sec><sec id="Sec23"><title>RT-qPCR</title><p id="Par59">For RT-qPCT analyses, 1&#x02009;<inline-formula id="IEq40"><alternatives><tex-math id="d33e2479">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2484"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>5</sup> to 2&#x02009;<inline-formula id="IEq41"><alternatives><tex-math id="d33e2490">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e2495"><mml:mo>&#x000d7;</mml:mo></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq6.gif"/></alternatives></inline-formula>&#x02009;10<sup>5</sup> cells were collected, and their RNA was extracted with the Quick-RNA Miniprep Kit (Zymo, R1054). cDNA was produced from 300&#x02009;ng of purified RNA using the SuperScript First-Strand Synthesis System for RT-qPCR (Invitrogen, 11904018). qPCR reactions were conducted with PowerUp SYBR Green Master Mix (Applied Biosystem, A25742) in a total volume of 10&#x02009;&#x000b5;L with 500&#x02009;nM primers following the manufacturer&#x02019;s protocol. Gene expression levels were normalized to <italic>ACT1B</italic> using the <inline-formula id="IEq42"><alternatives><tex-math id="d33e2505">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${-2}^{\Delta \Delta {C}_{t}}$$\end{document}</tex-math><mml:math id="d33e2510"><mml:msup><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq42.gif"/></alternatives></inline-formula> method<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>.</p></sec><sec id="Sec24"><title>Arrayed validation experiments in K562 cells</title><p id="Par60">To generate stable knockdown and cDNA-expressing cell lines for each gene of interest, we individually transduced the single CRISPRi Sp-sgRNA vectors listed in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref> into the CRISPRi (dCas9-BFP-KRAB) and dox-inducible rA1-SaBE4(&#x00394;UGI) K562 cell line at a MOI&#x02009;&#x0003c;&#x02009;0.3. This cell line was chosen for validation (rather than the dCas9-KRAB-MeCP2-P2A-mCherry-expressing cell line) as it demonstrated better knockdown efficiency during the screens based on essential gene depletion. Transduced cells were selected with a 3-day, 2.5 <inline-formula id="IEq43"><alternatives><tex-math id="d33e2539">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2544"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml puromycin treatment.</p><p id="Par61">For dox-induction experiment, stable knockdown K562 cells were treated with 100&#x02009;ng/ml doxycycline for seven days. ~100,000 cells were collected on day 7 and lysed using cell lysis buffer (10&#x02009;mM Tris, 0.05% SDS and 1.25&#x02009;U/ml proteinase K).</p><p id="Par62">For transfection experiments, 200,000 stable knockdown K562 cells were nucleofected with 800&#x02009;ng of base editor plasmid, encoding either rA1-SaBE4(&#x00394;UGI)-P2A-mCherry, rA1-SaBE4-P2A-mCherry or rA1-SaBE1-P2A-mCherry, and 200&#x02009;ng of sgRNA plasmid using the SF Cell Line 4D-Nucleofector X Kit S (Lonza, V4XC&#x02212;2032) and pulse program FF-120, according to the manufacturer&#x02019;s protocol. After nucleofection, cells were resuspended in RPMI and cultured in 12-well plates. Three days post transfection, transfected cells were collected by sorting the mCherry+ population on a Bio-Rad S3e cell sorter using Biorad ProSort software v1.6 and lysed using cell lysis buffer at a density of 1000 cells/&#x000b5;l.</p></sec><sec id="Sec25"><title>Arrayed validation experiments in HeLa cells</title><p id="Par63">To establish HeLa cell lines with stable knockdown of genes of interest, CRISPRi HeLa cells were transduced with the dual sgRNA vectors listed in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">5</xref> at a MOI&#x02009;&#x0003c;&#x02009;0.3. Two days post transduction, puromycin was applied at 1.5 <inline-formula id="IEq44"><alternatives><tex-math id="d33e2560">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2565"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml for 3 days to select for transduced cells. 350,000 cells from each HeLa&#x000a0;stable&#x000a0;knockdown cell line&#x000a0;were seeded in 2&#x02009;mL of media in 6-well plates and transfected 24&#x02009;h later with 3&#x02009;&#x000b5;g base editor plasmid, encoding either rA1-SaBE4(&#x00394;UGI)-P2A-mCherry or rA1-SaBE4-P2A-mCherry, and 750&#x02009;ng sgRNA plasmid. Three days post transfection, transfected cells were collected by sorting the mCherry+ population on a Bio-Rad S3e cell sorter using Biorad ProSort software v1.6 and lysed using cell lysis buffer at a density of 1000 cells/&#x000b5;l.</p></sec><sec id="Sec26"><title>Arrayed validation experiments in HEK293T cells</title><p id="Par64">To establish HEK293T cell lines with stable knockdown of genes of interest, 40,000 wildtype HEK293T cells were seeded in 250&#x02009;&#x003bc;L of media in 48-well plates and transfected 24&#x02009;h later with 180&#x02009;ng CRISPRoff_v2.1 (Addgene, #167981) and 90&#x02009;ng dual sgRNA vector<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. One day post transfection, puromycin was applied at 3 <inline-formula id="IEq45"><alternatives><tex-math id="d33e2578">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{\mu }}}}$$\end{document}</tex-math><mml:math id="d33e2583"><mml:mi mathvariant="normal">&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq7.gif"/></alternatives></inline-formula> g/ml for 3 days to select for transfected cells. All cell lines were then passaged for 7 days to allow for the degradation of the CRISPRoff and dual sgRNA vectors.</p><p id="Par65">For transfection, 40,000 cells from each HEK293T stable knockdown cell line were seeded in 250&#x02009;&#x003bc;L of media in 48-well plates and transfected 24&#x02009;h later with 400&#x02009;ng base editor plasmid, encoding either rA1-SaBE4(&#x00394;UGI)-P2A-GFP, rA1-SaBE4-P2A-GFP, or evo-BE4(&#x00394;UGI)-P2A-mCherry, and 100&#x02009;ng sgRNA vector. Three days post transfection, transfected cells were collected by sorting the GFP+ or mCherry+ population on a Bio-Rad S3e cell sorter and lysed using cell lysis buffer at a density of 1000 cells/&#x000b5;l.</p></sec><sec id="Sec27"><title>NGS sample preparation and data analysis for arrayed validation experiments</title><p id="Par66">Editing efficiencies of the target regions were quantified by targeted amplicon NGS. 0.5 to 2.5&#x02009;&#x000b5;L of cell lysis was added in a 12.5&#x02009;&#x000b5;L PCR reaction with 0.1 to 0.125&#x02009;&#x000b5;M primers for round 1 PCR and amplified for 25 cycles. After confirmation on a 2% agarose gel, round 2 PCR was performed to barcode samples with 8-12 cycles. Samples were pooled, purified by gel extraction, and then quantified by Qubit with the dsDNA HS assay kit. Sequencing was performed on an Illumina MiniSeq (2&#x02009;&#x000d7;&#x02009;151 paired end reads) per the manufacturer&#x02019;s instructions.</p><p id="Par67">Targeted amplicon NGS data were first processed using Illumina Local Run Manager Generate FASTQ analysis module (v2.0) on MiniSeq control software (v2.2.1) to demultiplex and trim Fastq files. Data were then analyzed using CRISPResso2 (version 2.0.20b) with default settings and the following options: --base_editor_output, -wc &#x02212;10, -w 10, --plot_window_size 10<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Alleles frequencies files were extracted for further analysis to generate tract plots.</p><p id="Par68">Z-scores were computed as follow:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="d33e2602">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$z=\frac{x-\mu }{\sigma }$$\end{document}</tex-math><mml:math id="d33e2608"><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>x</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003bc;</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41467_2025_59948_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq46"><alternatives><tex-math id="d33e2620">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="d33e2625"><mml:mi>&#x003bc;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq46.gif"/></alternatives></inline-formula> is the mean of negative controls, and <inline-formula id="IEq47"><alternatives><tex-math id="d33e2629">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma$$\end{document}</tex-math><mml:math id="d33e2634"><mml:mi>&#x003c3;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq47.gif"/></alternatives></inline-formula> is the standard deviation of negative control distribution.</p><p id="Par69">We computed adjusted z-scores for samples with multiple replicates:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="d33e2640">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{{\rm{adjusted}}}}\,{{{\rm{z}}}}-{{{\rm{score}}}}=|{{{\rm{mean}}}} \, ({{{\rm{z}}}})|{-}\sigma ({{{\rm{z}}}})$$\end{document}</tex-math><mml:math id="d33e2646"><mml:mi mathvariant="normal">adjusted</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">z</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">score</mml:mi><mml:mo>=</mml:mo><mml:mo>&#x02223;</mml:mo><mml:mi mathvariant="normal">mean</mml:mi><mml:mspace width="0.25em"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">z</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x02223;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003c3;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">z</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><graphic xlink:href="41467_2025_59948_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where |mean(z)| is the absolute value of the average z-score from multiple replicates, and <inline-formula id="IEq48"><alternatives><tex-math id="d33e2678">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma$$\end{document}</tex-math><mml:math id="d33e2683"><mml:mi>&#x003c3;</mml:mi></mml:math><inline-graphic xlink:href="41467_2025_59948_Article_IEq47.gif"/></alternatives></inline-formula>(z) is the standard deviation of the z-score distribution.</p></sec><sec id="Sec28"><title>Data visualization</title><p id="Par70">All processed data were visualized using Python 3.9.5, Pandas v1.4.2, Matplotlib v3.4.3, and/or Seaborn v0.11.2.</p></sec><sec id="Sec29"><title>Reporting summary</title><p id="Par71">Further information on research design is available in the&#x000a0;<xref rid="MOESM4" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec30" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2025_59948_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2025_59948_MOESM2_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2025_59948_MOESM3_ESM.xlsx"><caption><p>Supplementary Data 1&#x02013;7</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2025_59948_MOESM4_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2025_59948_MOESM5_ESM.pdf"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
</p></sec><sec id="Sec31" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2025_59948_MOESM6_ESM.xlsx"><caption><p>Source Data</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Sifeng Gu, Zsolt Bodai.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-025-59948-z.</p></sec><ack><title>Acknowledgements</title><p>This research was supported by the University of California, San Diego and the National Science Foundation through grant no. MCB-2048207 (to A.C.K). Z.B. was supported by the Research Corporation for Science Advancement through Cottrell fellowship no. 27975 (to Z.B.). R.A.A. was supported by the Chemistry-Biology Interfaces Training Grant, NIH Grant T32GM146648. We are grateful to Cody Fine, Mateo Espinoza and Mitra Banihassan (UCSD) for technical assistance with flow cytometry experiments. This work was additionally made possible by the UC San Diego Stem Cell Program and a CIRM Major Facilities grant (FA1-00607) to the Sanford Consortium for Regenerative Medicine. This publication includes data generated at the UCSD Human Embryonic Stem Cell Core Facility, using the BD FACSAria II and Fusion.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>S.G. contributed to conceptualization of the research project, experimental design, data curation, data analysis, and visualization, and writing of the manuscript. Z.B. contributed to conceptualization of the research project, funding acquisition, experimental design, data curation, data analysis, and writing of the manuscript. S.G. and Z.B. authors contributed equally of this manuscript. R.A.A. contributed to data curation. H.Y.A.S. contributed to data curation. Q.T.C. contributed to conceptualization of the research project and data curation. A.C.K. contributed to conceptualization of the research project, experimental design, data analysis, supervision of the work, writing of the manuscript, and acquisition of the funding. All authors contributed to editing of the manuscript.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par72"><italic>Nature Communications</italic> thanks Changhao Bi, Feilong Meng and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>The next-generation sequencing data generated in this study have been deposited in the NCBI Sequencing Read Archive (SRA) under project number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA1081436">PRJNA1081436</ext-link>. Plasmids generated in this study are available at Addgene (Addgene Plasmid #s 239447, 239448, 129450, 239461, 239462, and 239463).&#x000a0;<xref ref-type="sec" rid="Sec31">Source data</xref> are provided with this paper.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par73">A.C.K. is a member of the SAB of Pairwise Plants, is an equity holder for Pairwise Plants and Beam Therapeutics, and receives royalties from Pairwise Plants, Beam Therapeutics, and Editas Medicine via patents licensed from Harvard University. A.C.K.&#x02019;s interests have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. All other authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Porto</surname><given-names>EM</given-names></name><name><surname>Komor</surname><given-names>AC</given-names></name><name><surname>Slaymaker</surname><given-names>IM</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name></person-group><article-title>Base editing: advances and therapeutic opportunities</article-title><source>Nat. Rev. Drug Discov.</source><year>2020</year><volume>19</volume><fpage>839</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1038/s41573-020-0084-6</pub-id><pub-id pub-id-type="pmid">33077937</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Porto, E. M., Komor, A. C., Slaymaker, I. M. &#x00026; Yeo, G. W. Base editing: advances and therapeutic opportunities. <italic>Nat. Rev. Drug Discov.</italic><bold>19</bold>, 839&#x02013;859 (2020).<pub-id pub-id-type="pmid">33077937</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Lapinaite</surname><given-names>A</given-names></name><etal/></person-group><article-title>DNA capture by a CRISPR-Cas9&#x02013;guided adenine base editor</article-title><source>Science</source><year>2020</year><volume>369</volume><fpage>566</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1126/science.abb1390</pub-id><pub-id pub-id-type="pmid">32732424</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Lapinaite, A. et al. DNA capture by a CRISPR-Cas9&#x02013;guided adenine base editor. <italic>Science</italic><bold>369</bold>, 566&#x02013;571 (2020).<pub-id pub-id-type="pmid">32732424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Komor</surname><given-names>AC</given-names></name><name><surname>Kim</surname><given-names>YB</given-names></name><name><surname>Packer</surname><given-names>MS</given-names></name><name><surname>Zuris</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>DR</given-names></name></person-group><article-title>Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage</article-title><source>Nature</source><year>2016</year><volume>533</volume><fpage>420</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1038/nature17946</pub-id><pub-id pub-id-type="pmid">27096365</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. &#x00026; Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. <italic>Nature</italic><bold>533</bold>, 420&#x02013;424 (2016).<pub-id pub-id-type="pmid">27096365</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Krokan</surname><given-names>HE</given-names></name><name><surname>Drabl&#x000f8;s</surname><given-names>F</given-names></name><name><surname>Slupphaug</surname><given-names>G</given-names></name></person-group><article-title>Uracil in DNA &#x02013; occurrence, consequences and repair</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>8935</fpage><lpage>8948</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1205996</pub-id><pub-id pub-id-type="pmid">12483510</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Krokan, H. E., Drabl&#x000f8;s, F. &#x00026; Slupphaug, G. Uracil in DNA &#x02013; occurrence, consequences and repair. <italic>Oncogene</italic><bold>21</bold>, 8935&#x02013;8948 (2002).<pub-id pub-id-type="pmid">12483510</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Kurt</surname><given-names>IC</given-names></name><etal/></person-group><article-title>CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells</article-title><source>Nat. Biotechnol.</source><year>2021</year><volume>39</volume><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0609-x</pub-id><pub-id pub-id-type="pmid">32690971</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Kurt, I. C. et al. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. <italic>Nat. Biotechnol.</italic><bold>39</bold>, 41&#x02013;46 (2021).<pub-id pub-id-type="pmid">32690971</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>1384</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21559-9</pub-id><pub-id pub-id-type="pmid">33654077</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Chen, L. et al. Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins. <italic>Nat. Commun.</italic><bold>12</bold>, 1384 (2021).<pub-id pub-id-type="pmid">33654077</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Koblan</surname><given-names>LW</given-names></name><etal/></person-group><article-title>Efficient C&#x02022;G-to-G&#x02022;C base editors developed using CRISPRi screens, target-library analysis, and machine learning</article-title><source>Nat. Biotechnol.</source><year>2021</year><volume>39</volume><fpage>1414</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1038/s41587-021-00938-z</pub-id><pub-id pub-id-type="pmid">34183861</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Koblan, L. W. et al. Efficient C&#x02022;G-to-G&#x02022;C base editors developed using CRISPRi screens, target-library analysis, and machine learning. <italic>Nat. Biotechnol.</italic><bold>39</bold>, 1414&#x02013;1425 (2021).<pub-id pub-id-type="pmid">34183861</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Arbab</surname><given-names>M</given-names></name><etal/></person-group><article-title>Determinants of base editing outcomes from target library analysis and machine learning</article-title><source>Cell</source><year>2020</year><volume>182</volume><fpage>463</fpage><lpage>480.e30</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.037</pub-id><pub-id pub-id-type="pmid">32533916</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Arbab, M. et al. Determinants of base editing outcomes from target library analysis and machine learning. <italic>Cell</italic><bold>182</bold>, 463&#x02013;480.e30 (2020).<pub-id pub-id-type="pmid">32533916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>ME</given-names></name><etal/></person-group><article-title>C-to-G editing generates double-strand breaks causing deletion, transversion and translocation</article-title><source>Nat. Cell Biol.</source><year>2024</year><volume>26</volume><fpage>294</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41556-023-01342-2</pub-id><pub-id pub-id-type="pmid">38263276</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Huang, M. E. et al. C-to-G editing generates double-strand breaks causing deletion, transversion and translocation. <italic>Nat. Cell Biol.</italic><bold>26</bold>, 294&#x02013;304 (2024).<pub-id pub-id-type="pmid">38263276</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Bodai</surname><given-names>Z</given-names></name><name><surname>Cowan</surname><given-names>QT</given-names></name><name><surname>Komor</surname><given-names>AC</given-names></name></person-group><article-title>Base editors: expanding the types of DNA damage products harnessed for genome editing</article-title><source>Gene Genome Ed.</source><year>2021</year><volume>1</volume><fpage>100005</fpage><pub-id pub-id-type="doi">10.1016/j.ggedit.2021.100005</pub-id><pub-id pub-id-type="pmid">34368792</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Gu, S., Bodai, Z., Cowan, Q. T. &#x00026; Komor, A. C. Base editors: expanding the types of DNA damage products harnessed for genome editing. <italic>Gene Genome Ed.</italic><bold>1</bold>, 100005 (2021).<pub-id pub-id-type="pmid">34368792</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Mas-Ponte</surname><given-names>D</given-names></name><name><surname>Supek</surname><given-names>F</given-names></name></person-group><article-title>DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers</article-title><source>Nat. Genet.</source><year>2020</year><volume>52</volume><fpage>958</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-0674-6</pub-id><pub-id pub-id-type="pmid">32747826</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Mas-Ponte, D. &#x00026; Supek, F. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. <italic>Nat. Genet.</italic><bold>52</bold>, 958&#x02013;968 (2020).<pub-id pub-id-type="pmid">32747826</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Gallina</surname><given-names>I</given-names></name><etal/></person-group><article-title>The ubiquitin ligase RFWD3 is required for translesion DNA synthesis</article-title><source>Mol. Cell</source><year>2021</year><volume>81</volume><fpage>442</fpage><lpage>458.e9</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.11.029</pub-id><pub-id pub-id-type="pmid">33321094</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Gallina, I. et al. The ubiquitin ligase RFWD3 is required for translesion DNA synthesis. <italic>Mol. Cell</italic><bold>81</bold>, 442&#x02013;458.e9 (2021).<pub-id pub-id-type="pmid">33321094</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Kanao</surname><given-names>R</given-names></name><name><surname>Kawai</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Takata</surname><given-names>M</given-names></name><name><surname>Masutani</surname><given-names>C</given-names></name></person-group><article-title>RFWD3 and translesion DNA polymerases contribute to PCNA modification&#x02013;dependent DNA damage tolerance</article-title><source>Life Sci. Alliance</source><year>2022</year><volume>5</volume><fpage>e202201584</fpage><pub-id pub-id-type="doi">10.26508/lsa.202201584</pub-id><pub-id pub-id-type="pmid">35905994</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Kanao, R., Kawai, H., Taniguchi, T., Takata, M. &#x00026; Masutani, C. RFWD3 and translesion DNA polymerases contribute to PCNA modification&#x02013;dependent DNA damage tolerance. <italic>Life Sci. Alliance</italic><bold>5</bold>, e202201584 (2022).<pub-id pub-id-type="pmid">35905994</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Genome-Scale CRISPR-mediated control of gene repression and activation</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>647</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.029</pub-id><pub-id pub-id-type="pmid">25307932</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Gilbert, L. A. et al. Genome-Scale CRISPR-mediated control of gene repression and activation. <italic>Cell</italic><bold>159</bold>, 647&#x02013;661 (2014).<pub-id pub-id-type="pmid">25307932</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Brookhouser</surname><given-names>N</given-names></name><etal/></person-group><article-title>BIG-TREE: base-edited isogenic hpsc line generation using a transient reporter for editing enrichment</article-title><source>Stem Cell Rep.</source><year>2020</year><volume>14</volume><fpage>184</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.12.013</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Brookhouser, N. et al. BIG-TREE: base-edited isogenic hpsc line generation using a transient reporter for editing enrichment. <italic>Stem Cell Rep.</italic><bold>14</bold>, 184&#x02013;191 (2020).</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Heim</surname><given-names>R</given-names></name><name><surname>Tsien</surname><given-names>RY</given-names></name></person-group><article-title>Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer</article-title><source>Curr. Biol.</source><year>1996</year><volume>6</volume><fpage>178</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(02)00450-5</pub-id><pub-id pub-id-type="pmid">8673464</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Heim, R. &#x00026; Tsien, R. Y. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. <italic>Curr. Biol.</italic><bold>6</bold>, 178&#x02013;182 (1996).<pub-id pub-id-type="pmid">8673464</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Certo</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Tracking genome engineering outcome at individual DNA breakpoints</article-title><source>Nat. Methods</source><year>2011</year><volume>8</volume><fpage>671</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1648</pub-id><pub-id pub-id-type="pmid">21743461</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Certo, M. T. et al. Tracking genome engineering outcome at individual DNA breakpoints. <italic>Nat. Methods</italic><bold>8</bold>, 671&#x02013;676 (2011).<pub-id pub-id-type="pmid">21743461</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinstiver</surname><given-names>BP</given-names></name><etal/></person-group><article-title>Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition</article-title><source>Nat. Biotechnol.</source><year>2015</year><volume>33</volume><fpage>1293</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1038/nbt.3404</pub-id><pub-id pub-id-type="pmid">26524662</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. <italic>Nat. Biotechnol.</italic><bold>33</bold>, 1293&#x02013;1298 (2015).<pub-id pub-id-type="pmid">26524662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Komor</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity</article-title><source>Sci. Adv.</source><year>2017</year><volume>3</volume><fpage>eaao4774</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aao4774</pub-id><pub-id pub-id-type="pmid">28875174</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Komor, A. C. et al. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. <italic>Sci. Adv.</italic><bold>3</bold>, eaao4774 (2017).<pub-id pub-id-type="pmid">28875174</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>2052</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-15887-5</pub-id><pub-id pub-id-type="pmid">32345976</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Yu, Y. et al. Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity. <italic>Nat. Commun.</italic><bold>11</bold>, 2052 (2020).<pub-id pub-id-type="pmid">32345976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Gehrke</surname><given-names>JM</given-names></name><etal/></person-group><article-title>An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities</article-title><source>Nat. Biotechnol.</source><year>2018</year><volume>36</volume><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1038/nbt.4199</pub-id><pub-id pub-id-type="pmid">30059493</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Gehrke, J. M. et al. An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. <italic>Nat. Biotechnol.</italic><bold>36</bold>, 977&#x02013;982 (2018).<pub-id pub-id-type="pmid">30059493</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>NC</given-names></name><etal/></person-group><article-title>An enhanced CRISPR repressor for targeted mammalian gene regulation</article-title><source>Nat. Methods</source><year>2018</year><volume>15</volume><fpage>611</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1038/s41592-018-0048-5</pub-id><pub-id pub-id-type="pmid">30013045</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Yeo, N. C. et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. <italic>Nat. Methods</italic><bold>15</bold>, 611&#x02013;616 (2018).<pub-id pub-id-type="pmid">30013045</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Iyengar</surname><given-names>S</given-names></name><name><surname>Farnham</surname><given-names>PJ</given-names></name></person-group><article-title>KAP1 Protein: an enigmatic master regulator of the genome</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>26267</fpage><lpage>26276</lpage><pub-id pub-id-type="doi">10.1074/jbc.R111.252569</pub-id><pub-id pub-id-type="pmid">21652716</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Iyengar, S. &#x00026; Farnham, P. J. KAP1 Protein: an enigmatic master regulator of the genome. <italic>J. Biol. Chem.</italic><bold>286</bold>, 26267&#x02013;26276 (2011).<pub-id pub-id-type="pmid">21652716</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Niida</surname><given-names>H</given-names></name><etal/></person-group><article-title>Phosphorylated HBO1 at UV irradiated sites is essential for nucleotide excision repair</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>16102</fpage><pub-id pub-id-type="doi">10.1038/ncomms16102</pub-id><pub-id pub-id-type="pmid">28719581</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Niida, H. et al. Phosphorylated HBO1 at UV irradiated sites is essential for nucleotide excision repair. <italic>Nat. Commun.</italic><bold>8</bold>, 16102 (2017).<pub-id pub-id-type="pmid">28719581</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>M</given-names></name><etal/></person-group><article-title>The G-Quadruplex-Specific RNA Helicase DHX36 Regulates p53 Pre-mRNA 3&#x02032;-End processing following UV-Induced DNA Damage</article-title><source>J. Mol. Biol.</source><year>2017</year><volume>429</volume><fpage>3121</fpage><lpage>3131</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.11.033</pub-id><pub-id pub-id-type="pmid">27940037</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Newman, M. et al. The G-Quadruplex-Specific RNA Helicase DHX36 Regulates p53 Pre-mRNA 3&#x02032;-End processing following UV-Induced DNA Damage. <italic>J. Mol. Biol.</italic><bold>429</bold>, 3121&#x02013;3131 (2017).<pub-id pub-id-type="pmid">27940037</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Deh&#x000e9;</surname><given-names>P-M</given-names></name><name><surname>Gaillard</surname><given-names>P-HL</given-names></name></person-group><article-title>Control of structure-specific endonucleases to maintain genome stability</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2017</year><volume>18</volume><fpage>315</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.177</pub-id><pub-id pub-id-type="pmid">28327556</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Deh&#x000e9;, P.-M. &#x00026; Gaillard, P.-H. L. Control of structure-specific endonucleases to maintain genome stability. <italic>Nat. Rev. Mol. Cell Biol.</italic><bold>18</bold>, 315&#x02013;330 (2017).<pub-id pub-id-type="pmid">28327556</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Prindle</surname><given-names>MJ</given-names></name><name><surname>Loeb</surname><given-names>LA</given-names></name></person-group><article-title>DNA polymerase delta in dna replication and genome maintenance</article-title><source>Environ. Mol. Mutagen.</source><year>2012</year><volume>53</volume><fpage>666</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1002/em.21745</pub-id><pub-id pub-id-type="pmid">23065663</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Prindle, M. J. &#x00026; Loeb, L. A. DNA polymerase delta in dna replication and genome maintenance. <italic>Environ. Mol. Mutagen.</italic><bold>53</bold>, 666&#x02013;682 (2012).<pub-id pub-id-type="pmid">23065663</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Edelbrock</surname><given-names>MA</given-names></name><name><surname>Kaliyaperumal</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>KJ</given-names></name></person-group><article-title>Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities</article-title><source>Mutat. Res. Mol. Mech. Mutagen.</source><year>2013</year><volume>743&#x02013;744</volume><fpage>53</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2012.12.008</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Edelbrock, M. A., Kaliyaperumal, S. &#x00026; Williams, K. J. Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities. <italic>Mutat. Res. Mol. Mech. Mutagen.</italic><bold>743&#x02013;744</bold>, 53&#x02013;66 (2013).</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Trojan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system</article-title><source>Gastroenterology</source><year>2002</year><volume>122</volume><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1053/gast.2002.30296</pub-id><pub-id pub-id-type="pmid">11781295</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Trojan, J. et al. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. <italic>Gastroenterology</italic><bold>122</bold>, 211&#x02013;219 (2002).<pub-id pub-id-type="pmid">11781295</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Thuronyi</surname><given-names>BW</given-names></name><etal/></person-group><article-title>Continuous evolution of base editors with expanded target compatibility and improved activity</article-title><source>Nat. Biotechnol.</source><year>2019</year><volume>37</volume><fpage>1070</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0193-0</pub-id><pub-id pub-id-type="pmid">31332326</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Thuronyi, B. W. et al. Continuous evolution of base editors with expanded target compatibility and improved activity. <italic>Nat. Biotechnol.</italic><bold>37</bold>, 1070&#x02013;1079 (2019).<pub-id pub-id-type="pmid">31332326</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Elia</surname><given-names>AEH</given-names></name><etal/></person-group><article-title>RFWD3-Dependent Ubiquitination of RPA regulates repair at stalled replication forks</article-title><source>Mol. Cell</source><year>2015</year><volume>60</volume><fpage>280</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.011</pub-id><pub-id pub-id-type="pmid">26474068</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Elia, A. E. H. et al. RFWD3-Dependent Ubiquitination of RPA regulates repair at stalled replication forks. <italic>Mol. Cell</italic><bold>60</bold>, 280&#x02013;293 (2015).<pub-id pub-id-type="pmid">26474068</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>ED</given-names></name><name><surname>Bednarski</surname><given-names>DW</given-names></name><name><surname>Maizels</surname><given-names>N</given-names></name></person-group><article-title>High-fidelity correction of genomic uracil by human mismatch repair activities</article-title><source>BMC Mol. Biol.</source><year>2008</year><volume>9</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.1186/1471-2199-9-94</pub-id><pub-id pub-id-type="pmid">18954457</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Larson, E. D., Bednarski, D. W. &#x00026; Maizels, N. High-fidelity correction of genomic uracil by human mismatch repair activities. <italic>BMC Mol. Biol.</italic><bold>9</bold>, 94 (2008).<pub-id pub-id-type="pmid">18954457</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Rada</surname><given-names>C</given-names></name><name><surname>Di Noia</surname><given-names>JM</given-names></name><name><surname>Neuberger</surname><given-names>MS</given-names></name></person-group><article-title>Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-Focused phase of somatic mutation</article-title><source>Mol. Cell</source><year>2004</year><volume>16</volume><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.10.011</pub-id><pub-id pub-id-type="pmid">15494304</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Rada, C., Di Noia, J. M. &#x00026; Neuberger, M. S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-Focused phase of somatic mutation. <italic>Mol. Cell</italic><bold>16</bold>, 163&#x02013;171 (2004).<pub-id pub-id-type="pmid">15494304</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiricny</surname><given-names>J</given-names></name></person-group><article-title>The multifaceted mismatch-repair system</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2006</year><volume>7</volume><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1038/nrm1907</pub-id><pub-id pub-id-type="pmid">16612326</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Jiricny, J. The multifaceted mismatch-repair system. <italic>Nat. Rev. Mol. Cell Biol.</italic><bold>7</bold>, 335&#x02013;346 (2006).<pub-id pub-id-type="pmid">16612326</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x000f1;a-Diaz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Noncanonical mismatch repair as a source of genomic instability in human cells</article-title><source>Mol. Cell</source><year>2012</year><volume>47</volume><fpage>669</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.07.006</pub-id><pub-id pub-id-type="pmid">22864113</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Pe&#x000f1;a-Diaz, J. et al. Noncanonical mismatch repair as a source of genomic instability in human cells. <italic>Mol. Cell</italic><bold>47</bold>, 669&#x02013;680 (2012).<pub-id pub-id-type="pmid">22864113</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Sale, J. E. Competition, collaboration and coordination &#x02013; determining how cells bypass DNA damage. <italic>J. Cell Sci</italic>. 094748. 10.1242/jcs.094748 (2012).</mixed-citation></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Sale</surname><given-names>JE</given-names></name><name><surname>Translesion</surname><given-names>DNA</given-names></name></person-group><article-title>Synthesis and Mutagenesis in Eukaryotes</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2013</year><volume>5</volume><fpage>a012708</fpage><lpage>a012708</lpage><pub-id pub-id-type="doi">10.1101/cshperspect.a012708</pub-id><pub-id pub-id-type="pmid">23457261</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Sale, J. E. &#x00026; Translesion, D. N. A. Synthesis and Mutagenesis in Eukaryotes. <italic>Cold Spring Harb. Perspect. Biol.</italic><bold>5</bold>, a012708&#x02013;a012708 (2013).<pub-id pub-id-type="pmid">23457261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Combinatorial CRISPR&#x02013;Cas9 screens for de novo mapping of genetic interactions</article-title><source>Nat. Methods</source><year>2017</year><volume>14</volume><fpage>573</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4225</pub-id><pub-id pub-id-type="pmid">28319113</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Shen, J. P. et al. Combinatorial CRISPR&#x02013;Cas9 screens for de novo mapping of genetic interactions. <italic>Nat. Methods</italic><bold>14</bold>, 573&#x02013;576 (2017).<pub-id pub-id-type="pmid">28319113</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Bitinaite</surname><given-names>J</given-names></name><etal/></person-group><article-title>USERTM friendly DNA engineering and cloning method by uracil excision</article-title><source>Nucleic Acids Res.</source><year>2007</year><volume>35</volume><fpage>1992</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm041</pub-id><pub-id pub-id-type="pmid">17341463</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Bitinaite, J. et al. USERTM friendly DNA engineering and cloning method by uracil excision. <italic>Nucleic Acids Res.</italic><bold>35</bold>, 1992&#x02013;2002 (2007).<pub-id pub-id-type="pmid">17341463</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Engler, C. &#x00026; Marillonnet, S. Golden Gate Cloning. In <italic>DNA Cloning and Assembly Methods</italic> (<italic>eds</italic>. Valla, S. &#x00026; Lale, R.) vol. 1116 119&#x02013;131 (Humana Press, 2014).</mixed-citation></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Replogle</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors</article-title><source>eLife</source><year>2022</year><volume>11</volume><fpage>e81856</fpage><pub-id pub-id-type="doi">10.7554/eLife.81856</pub-id><pub-id pub-id-type="pmid">36576240</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Replogle, J. M. et al. Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors. <italic>eLife</italic><bold>11</bold>, e81856 (2022).<pub-id pub-id-type="pmid">36576240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>CD</given-names></name><etal/></person-group><article-title>CRISPR&#x02013;Cas9 genome editing in human cells occurs via the Fanconi anemia pathway</article-title><source>Nat. Genet.</source><year>2018</year><volume>50</volume><fpage>1132</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0174-0</pub-id><pub-id pub-id-type="pmid">30054595</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Richardson, C. D. et al. CRISPR&#x02013;Cas9 genome editing in human cells occurs via the Fanconi anemia pathway. <italic>Nat. Genet.</italic><bold>50</bold>, 1132&#x02013;1139 (2018).<pub-id pub-id-type="pmid">30054595</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Horlbeck</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation</article-title><source>eLife</source><year>2016</year><volume>5</volume><fpage>e19760</fpage><pub-id pub-id-type="doi">10.7554/eLife.19760</pub-id><pub-id pub-id-type="pmid">27661255</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. <italic>eLife</italic><bold>5</bold>, e19760 (2016).<pub-id pub-id-type="pmid">27661255</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><fpage>554</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0554-4</pub-id><pub-id pub-id-type="pmid">25476604</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. <italic>Genome Biol.</italic><bold>15</bold>, 554 (2014).<pub-id pub-id-type="pmid">25476604</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute</article-title><source>Nat. Protoc.</source><year>2019</year><volume>14</volume><fpage>756</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1038/s41596-018-0113-7</pub-id><pub-id pub-id-type="pmid">30710114</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Wang, B. et al. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. <italic>Nat. Protoc.</italic><bold>14</bold>, 756&#x02013;780 (2019).<pub-id pub-id-type="pmid">30710114</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x02009;&#x02212;&#x02009;&#x00394;&#x00394;CT Method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Livak, K. J. &#x00026; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x02009;&#x02212;&#x02009;&#x00394;&#x00394;CT Method. <italic>Methods</italic><bold>25</bold>, 402&#x02013;408 (2001).<pub-id pub-id-type="pmid">11846609</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Nu&#x000f1;ez</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>2503</fpage><lpage>&#x02212;2519.e17</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.03.025</pub-id><pub-id pub-id-type="pmid">33838111</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Nu&#x000f1;ez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. <italic>Cell</italic><bold>184</bold>, 2503&#x02013;&#x02212;2519.e17 (2021).<pub-id pub-id-type="pmid">33838111</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>K</given-names></name><etal/></person-group><article-title>CRISPResso2 provides accurate and rapid genome editing sequence analysis</article-title><source>Nat. Biotechnol.</source><year>2019</year><volume>37</volume><fpage>224</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0032-3</pub-id><pub-id pub-id-type="pmid">30809026</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. <italic>Nat. Biotechnol.</italic><bold>37</bold>, 224&#x02013;226 (2019).<pub-id pub-id-type="pmid">30809026</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>